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 Hippocrates, the father of medicine coined the term “Karkinos” for the 
non healing neoplastic ulcers and “Karkinoma’’ for the solid malignant 
tumours.  Both the terms derived from Greek. “Karkinos” means “Crab’’. The 
reason behind the terminology is the malignant tumors adhere to any 
part,which it seizes upon in an obstinate manner like crab.
1 
  The term “Oral cancer’’ is used to describe any malignancy that arises 
from the oral tissues. Oral cancer is the most life threatening disease of oral 
tissues, causing a major health problem in India
1
.Oral cancer is the sixth most 
common cancer worldwide and continues to be the most prevalent cancer 
related to the consumption of tobacco, arecanut, alcohol and other carcinogenic 
products. 
           Several studies have shown clearly that oral cancer usually preceded by 
Potentially malignant disorders. Some of these lesions share the same 
etiological factors with oral cancer, particularly the use of tobacco and areca 
nut exhibit the same site and habit relationship.  Individuals with Potentially 
malignant disorders such as oral leukoplakia and oral submucous fibrosis run a 
risk that is 69 times higher for them to develop oral cancer compared to 
tobacco users who do not have pre cancer.2 
 In recent years, emphasis has been placed on detecting molecular 
markers from body fluids such as saliva, urine and others, for detecting, 
predicting prognosis, and monitoring the oral cancer progression. The idea of 
screening and following patients with malignancy by blood based tests is 
appealing from several points of view including its ease, economic advantage, 
non invasiveness, and possibility of repeated sampling.
3
 Lipoproteins are 
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clusters of proteins and lipids, all tangled up together to carry lipids in our 
blood.  
        Several authors propose that hypocholesterolemia is a predisposing factor 
for cancer development.
4 
The habit of tobacco consumption is a known  
etiologic factor for development of Oral Potentially malignant disorders and 
Oral cancer. Patients with Potentially malignant disorders have also been  
reported to show a significant tendency to develop cancer. In oral cancer 
development, tobacco plays an etiologic role. It is believed that tobacco 
carcinogens induce generation of free radicals and reactive oxygen species 
responsible for the high rate of oxidation/peroxidation of polyunsaturated fatty 
acids which affects the cell membrane and are thus involved in carcinogenesis. 
Because of the lipid peroxidation, there is a greater utilization of lipids for new 
membrane biogenesis.
5
  
         This study is conducted to understand the role of these lipids in the oral 
potentially malignant disorders like Oral leukoplakia, Oral submucous fibrosis 
and also in Oral Squamous Cell Carcinoma . It can be suggested that Serum 
lipid status may be considered as a useful indicator for initial changes 
occurring in the neoplastic cells.  
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AIM: 
To evaluate the serum lipid profile in Potentially malignant disorders 
like Oral Leukoplakia, Oral Submucous fibrosis and also in Oral squamous 
cell carcinoma. 
OBJECTIVES: 
1.  To determine the serum levels of Total cholesterol, Low density 
lipoprotein, High density lipoprotein, Very Low density lipoprotein, 
Triglycerides of patients with Potentially malignant disorders like 
Oral Leukoplakia, Oral Submucous fibrosis.  
2. To determine the serum levels of Total cholesterol, Low density 
lipoprotein, High density lipoprotein, Very Low density lipoprotein, 
Triglycerides of patients with Oral squamous cell carcinoma. 
3. To compare these levels with the control group, Potentially 
malignant disorders as well as  in  Oral squamous cell carcinoma. 
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The study is about the Evaluation of serum lipid profile in Oral 
Potentially Malignant disorders and Oral Squamous cell carcinoma in 
comparison with healthy normal controls.  To obtain a meaningful study and 
result, a proper and detailed review of the literature is of utmost importance. 
The present literature reviews the various aspects of Oral leukoplakia, Oral 
submucous fibrosis which are Potentially malignant disorders and Oral 
Squamous cell carcinoma. A correlation of Serum lipid levels in the above 
disease condition as well as in the control groups are being presented. 
POTENTIALLY MALIGNANT DISORDERS  
A new terminology has been recommended for earlier lesions which 
were grouped under Premalignant lesions and conditions as “Potentially 
malignant disorders” which included not only the Premalignant lesions 
and conditions but also includes a family of morphological alterations 
among which few may have an increased potential for malignant 
transformation. The Potentially malignant disorders include Leukoplakia 
and Erythroplakia, Palatal lesion of reverse cigar smoking, Oral lichen 
planus, Oral submucous fibrosis, Discoid lupus erythematosus, hereditary 
disorders such as Dyskeratosis congenita and Epidermolysis bullosa. The 
recognition and management of these potentially malignant disorders 
therefore constitutes a vital oral cancer control measure.  But currently they 
recommend not dividing them as such, but instead clubbing them together 
under the heading of “Potentially malignant Disorders”. 2 
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ORAL LEUKOPLAKIA: 
Definition: 
WHO collaborating centre for oral precancerous lesion
6
 defined 
oral leukoplakia as “A white patch or plaque that cannot be characterized 
clinically or pathologically as any other disease.” 
Axell T et al
 7
 defined leukoplakia as “A white patch or plaque that 
cannot be characterized clinically or pathologically as anyother disease and 
is not associated with any physical or chemical causative agent except the 
use of tobacco”. 
Axell T et al 
7
 also defined oral leukoplakia as “A predominantly 
white lesion of oral mucosa that cannot be characterised as any other 
definable lesion;some leukoplakia will transform in to cancer. 
Pindborg et al 
8 defined leukoplakia as “A predominantly white 
lesion of the oral mucosa that cannot be characterized as any other definable 
lesion”. 
WHO 
6 declared “Leukoplakia should be used to recognize white 
patch of questionable risk having excluded other known diseases or 
disorders that carry no increased risk for cancer 
Historical review: 
Erno Schwimmer 
6
,a Hungarian dermaltologist was the first person 
to describe Oral Leukoplakia. He originally proposed the term 
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“Leukoplakia” which literally means “White patch”.  In Greek “Leukos” 
means white and “Plakia” means patch. It describes a clinical entity. 
Sprage 
6
 found that 36% of American oral pathologists used Oral 
leukoplakia as clinical term and 40% as histological one.  
Shafer 
6
 suggested that histological definition of leukoplakia is 
however complicated by the fact that not all lesion satisfying the 
histological criteria for leukoplakia will appear clinically as a white patch. 
         W.H.O Collaborating Centre for Oral Precancerous Lesions 
6 
proposed that the term Leukoplakia should be used to describe a clinical 
entity, that is a white patch of oral mucosa which is not removed by rubbing 
and not classifiable as any other oral disease like oral lichen planus, 
leukedema, candidiasis ,white sponge nevus, lupus erythematosus. It also 
suggests that microscopically leukoplakic lesions should be described in 
internationally approved term. 
Brad W. Neville 
9
 proposed that as such leukoplakia should be used 
only as a clinical term and it has no specific histopathological connation 
should never be used as microscopic diagnosis.  Sometimes a white patch is 
initially believed to represent leukoplakia, but the biopsy reveals another 
specific diagnosis.  In such cases, the lesion should no longer be categorized 
as leukoplakia 
Epidemiology: 
In a 10 year prospective study in India in large samples, carried out 
in several geographic areas with various kinds of tobacco usage, the annual 
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age- adjusted incidence rates of leukoplakia per 1000 population per year  
varied from 1.1 -2.4 among men and from 0.2 -1.3 among women and  the 
prevalence varied from 0.2-4.9%. 
10 
The annual incidence was 2.1 per 1000 men 1.3 per 1000 women 
and the  highest being in people with mixed habits, that 6 per 1000.
11 
Prevalence of leukoplakia in India varies from 0.2-5.2%. Prevalence 
of 0.59 also has been reported
. 12 
Prevalence of leukoplakia was reported to be 3.6% and that of 
preleukoplakia was 6.4%.  Idiopathic leukoplakia was reported to be 0.7% 
and tobacco specific leukoplakia was 2.9%. 
13  
            Less than 15 of men below the age of 30 years, have leukoplakia, but 
the prevalence increases to an alarming 8% in men over the age of 70 years. 
The prevalence in women past the age 70 years is approximately 2%.
14   
Etiology: 
Many causative agents have been implicated in the etiology of 
leukoplakia.  They include Tobacco, Alcohol, Chronic friction due to sharp 
tooth, Electro galvanic reaction, Ultra violet radiation, Syphilis. 
15
  
Tobacco use is considered to be the primary cause for the occurrence 
of leukoplakia. Leukoplakia associated with smoking habit seems to have 
less malignant potential than those not related to smoking habit.  In a study 
of 257 patients with oral leukoplakia, 183 were smokers, out of whom 12% 
developed carcinomas, whereas 74 were non- smokers out of whom 32% 
developed carcinoma. 
2,15
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Sugár.L. et al 
16
, made a follow-up study with 324 patients and 
concluded that there was a relationship between smoking and the frequency 
of leukoplakia. He also found that alcohol, mechanical irritants and electric 
potential difference in the mouth were also important etiological factors, 
particularly in combination. Many of the cases with mild symptoms 
improved when the etiological agent was removed. 
Dietrich T,
17 
made an analytical study on Clinical risk factors of oral 
leukoplakia and found the results as, Tobacco smoking as the strongest 
independent risk factor. The Odds Ratio were 3.00 (0.77-11.8) for < for =10 
cigarettes/day and up to 6.01 (2.4-15.0) for >20 cigarettes/day. Diabetes, age 
and socio-economic status were found as independent predictors of Oral 
leukoplakia. Alcohol consumption, race/ethnicity, years of education and 
Body Mass Index showed no independent association with  Oral leukoplakia 
Females  with a history of estrogen use were less likely to have Oral 
leukoplakia with an Odds ratio  of 0.34 (0.11-1.07).  
Thomas SJ, et al 
18
 conducted a cross sectional study on Betel quid 
not containing tobacco and oral leukoplakia .The study recruited 1,670 
adults. They recorded betel quid chewing and smoking. The prevalence of 
leukoplakia was 11.7%. In the nested case-control study of 197 cases and 
1,282 controls, current betel chewing was associated with increased risk of 
leukoplakia with an adjusted odds ratio for current chewers of 3.8 (95% CI 
1.7, 8.4) and in the heaviest chewers of 4.1 (95% CI 1.8, 9.1) compared to 
non-chewers. Current smoking was associated with an increased risk of 
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leukoplakia with an adjusted odds ratio for current smokers of 6.4 (95% CI 
4.1, 9.9) and amongst heaviest smokers of 9.8 (95% CI 5.9, 16.4) compared 
to non-smokers. The systematic review identified 5 studies examining risk 
of leukoplakia associated with betel quid chewing in populations where 
betel quid did not contain tobacco and that controlled for smoking. In 
studies that adjusted for smoking, the combined random effect odds ratio 
was 7.9 (95% CI 4.3, 14.6) in betel quid chewers. The results of this study 
and systematic review of similar studies provide evidence of the role of 
betel quid not containing tobacco and leukoplakia       
Prakash C.Guptha 
19
 made an Epidemiologic study of the 
association between alcohol habits and oral leukoplakia. The study included 
10914 individuals for their tobacco and alcohol habits and examined for the 
presence of oral leukoplakia. Very few females (1.6%) were found to be 
alcohol users and they were excluded from further analysis. Among 7604 
males, 30.4% used alcohol regularly, 25.4% occasionally and 44.2% were 
non-users. The prevalence of leukoplakia was significantly higher among 
regular (5.7%) and occasional (3.9%) users than among non-users (2.9%) of 
alcohol.  
Alcohol usage was found to be related to age as well as tobacco 
habits. The prevalence of leukoplakia was higher among alcohol users in 
each age-group as well as in each tobacco habit category. After age-
adjustment the difference between alcohol users and non-users, although 
reduced, remained significant. For most tobacco habit categories the trend 
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remained similar after age-adjustment except for the mixed habits group, for 
which there was a reversal of the trend. The alcohol habit may, perhaps, 
produce discernible effects only in association with other 'weak' etiological 
risk factors, such as a single tobacco habit of smoking or chewing rather 
than a 'strong' etiologic factor such as the mixed habits of chewing and 
smoking.  
Local factors like chronic irritation and malocclusion which 
constantly irritate the oral mucosa cause oral leukoplakia.  Irritation by ill 
fitting dentures, overhanging crowns and fillings and poor restoration refers 
to traumatic causes.  Smoking is also considered as an irritant due to drying 
effect on the mucosa.  These exciting factors should act on a susceptible 
host. Heredity plays an important role in determining an individual’s 
susceptibility or resistance to the development of leukoplakia. 
11 
            Systemic factors include hormonal alterations and nutritional 
deficiencies.  Estrogen deficiency may determine the susceptibility of 
females to develop leukoplakia at the period of menopause.   
            Vitamin A deficiency may produce Hyperkeratosis in experimental 
animal. Continuous irritants such as spicy food may also be a factor.  
Irritating mouthwashes can also be a cause but the exact role is yet to be 
substantiated.   
            Syphilis may also be responsible for leukoplakic lesions on tongue 
secondary to atrophic glossitis of tertiary syphilis.  The glossitis is 
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apparently more highly susceptible to the action of local irritants in the 
mouth. 
15 
               In one preliminary study Epstein Barr virus was detected in 60% 
of Proliferative verrucous leukoplakia cases suggesting its possibility as an 
etiological agent. 
              Yeast organism especially candida albicans can cause leukoplakia 
since it has the ability to form N-Nitrosomethylamines from the precursors 
which are abundantly available in the saliva of smokers.  
To list them under a table as 
15
: 
Local Systemic 
Local irritation 
 Sharp ,malposed teeth 
 Ill fitting denture 
 Poor restorations 
 
Heredity 
Occlusal disharmony Hormonal factors 
Occlusal habit Estrogen deficiency 
Thermal factors Nutritional deficiency 
Smoking Syphilis 
Irritant foods,chemicals,mouthwashes, etc. Atrophic glossitis 
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Clinical types 
6
 : 
Two main type exists: 
 Homogeneous 
 Non homogeneous 
 Distinction between these two forms is purely clinical, based on 
surface color and morphological characteristics like thickness which also 
has predilection for prognosis. 
Homogeneous type: 
          Homogeneous leukoplakia has been defined as a predominantly white 
lesion of uniform flat, thin appearance that may exhibit shallow cracks and 
has a smooth, wrinkled or corrugated surface with a constant texture 
throughout.  The risk of malignant transformation is relatively low. The 
lesion is predominantly white but can be grayish white.  It constitutes for 
about 84% of the leukoplakia. 
Non homogeneous type: 
 Ulcerative: Mixed white and red in color but retaining the 
predominant white character. 
 Nodular (Speckled): Small polypoid outgrowths, rounded red or 
white excrescences. 
 Verrucous: wrinkled or corrugated surface appearance. 
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The term “Erythro leukoplakia” is applied for predominantly red and 
white lesion that may be irregularly flat, nodular or exophytic.  The nodular 
lesions are characterized by white patches or nodules on a erythematous 
base. 
Ulcerative leukoplakia: 
Ulcerative leukoplakia is characterized by areas of red which at 
times exhibit yellowish areas of fibrin.  White patches are generally present 
at the periphery.  It constitutes to about 135 of all leukoplakia types. It could 
also present with ulceration with white areas in between.  Sometimes they 
occur with minimal keratinisation 
Verrucous leukoplakia; 
Verrucous leukoplakia appears as an exophytic lesion with irregular 
sharp or blunt projections.   
Clinical Features: 
Age:  
The onset of lesions usually starts after 30 years, resulting in peak 
incidence of 50 years.  Leukoplakia is seen most frequently in middle aged 
and older men, with an increasing prevalence with age.  Oral leukoplakia 
can occur 5 years prior to oral cancer.
14,20
 
Gender: 
It has a strong male preponderance. Leukoplakia is a commonly 
occurring lesion particularly in patients after 40 years of age. The male to 
female ratio is 2:1.  The gender distribution in most studies varies, ranging 
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from a strong male predominance in different parts of India, to almost 1:1 in 
Western world.
11
 
Site : 
Oral leukoplakia accounts for 80% of all leukoplakia of upper aero 
digestive tract. Most of the others are vocal cord lesions and are called as 
laryngeal keratosis.  It can occur anywhere in the oral cavity.  The site of 
leukoplakia depends on the type of smoking habit, the quality and the 
quantity of the tobacco. 
Most commonly involved sites are retro commissural area, buccal 
mucosa, edentulous alveolar ridge, hard palate, tongue, lips.  The gingival, 
soft palate and floor of mouth are less commonly involved in an Indian 
population, where as it is not true for Western population.  
        Waldron CA, Shafer WG.
20
 made a clinico pathologic study with 
3256 oral leukoplakia cases. During a 13-year period, 3256 specimens 
clinically diagnosed as leukoplakia ("keratosis," "white patch") were 
analyzed as to age of occurrence, site of involvement. 
            It was found that leukoplakia occurs chiefly in the 5th, 6th, and 7th 
decades; about half of the lesions involved the mandibular mucosa, 
mandibular sulcus, and buccal mucosa; leukoplakia was slightly more 
common in men (54.2%). 
            Bánóczy J 
21
 made a follow-up study with 670 patients with oral 
leukoplakia during a 30-year-period showed cancer development in 40 
cases. The age distribution revealed the prevalence of leukoplakia in the 
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age-group 51-60 years; that of carcinoma in the age-group of 61-70 years. 
The sex distribution showed a male-female ratio of 3.2 : 1 in the 
leukoplakia-group, and a 1.9 : 1 ratio in the carcinoma-group. The tongue 
and the lips were the site of predilection for malignant transformation and 
for dysplasia. Among etiological factors, Candida albicans infection and the 
simultaneous existence of several etiological factors seemed to play a role in 
malignant transformation. Erosive leukoplakia showed the highest risk, 
developing in 25.9% of the cases into cancer. 
Leukoplakia begins as thin, gray white plaques that may appear 
somewhat translucent, sometimes fissured or wrinkled and are soft and flat.   
They usually have sharply demarcated borders but occasionally 
blend gradually in to normal mucosa.  This early stage is considered as 
Phase –I Leukoplakia.   
Thin leukoplakia may continue unchanged or disappear, but with 
time 2/3
rd
 of these lesions acquire a distinct white appearance from a 
thickened keratin layer. It becomes leathery to palpation and fissures 
deepen.  There may be few or localized nodules or appear as surface 
projections.  This can be categorized as Phase-II.  
 Most of these lesions remain unchanged and about 2/3
rd
 regress and 
disappear and few become severe.  Later these lesions develop surface 
irregularities of a nodular or granular leukoplakia.  Numerous pointed 
projections develop on the surface and give an appearance of verruciform 
leukoplakia.  Both these lesions are Phase-III lesions with similar progress.  
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Phase-III lesions may become dysplastic or invasive with no change in 
clinical appearance.   
Over time an additional surface change occurs and multiple circular 
or oval patches of non blanching redness appear in scattered areas.  Such 
areas represent site at which cells are so immature that they are unable to 
produce keratin.  These forms Phase-IV lesions.   
Leukoplakia Clinical phases 
15:
 
Phase Descriptive terms Risk of malignant 
transformation 
 
I 
Thin leukoplakia 
Preleukoplakia 
Homogeneous 
leukoplakia 
 
+/- 
 
II 
Thick,smooth 
leukoplakia 
Fissured leukoplakia 
Homogeneous 
leukoplkia 
 
++ 
 
 
 
III 
Granular leukoplakia 
Verruciform 
leukoplakia 
Rough leukoplakia 
 
 
+++ 
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Candidal epithelial 
hyperplasia 
Homogeneous 
leukoplakia 
 
 
IV 
Erythroleukoplakia 
Speckled leukoplakia 
Candidal leukoplakia 
Nonhomogeneous 
leukoplakia 
 
++++ 
                   
Pindborg et al 
8
 has given the classification and staging for 
leukoplakia as follows, 
Classification and staging of oral leukoplakia   
Provisional (Clinical Diagnosis) 
L : Extent of leukoplakia 
          L0 : No evidence of lesion 
          L1 : ≤ 2 cm 
          L2 : 2-4 cm 
          L3 : ≥ 4cm 
S : Site of leukoplakia 
          S1 : all sites excluding floor of mouth & tongue 
          S2 : floor of mouth &/ tongue 
          S3 : not specified 
Review of Literature 
  
18 
 
C : Clinical aspect 
           C1 : homogeneous 
           C2 : non homogeneous 
           C3 : not specified 
Definitive diagnosis:( Histopathological diagnosis) 
P : Histopathological features 
P1 : no dysplasia 
P2 : Mild dysplasia 
P3 : Moderate dysplasia 
P4 : severe dysplasia 
Px : not specified 
Staging: 
1. any L,S1,C1,P1 or P2 
2. any L,S1or S2,C2,P1 or P2 
3. any L,S2,C2,P1 or P2   
4. any L,any S,any C,P3 or P4. 
Natural History: 
Leukoplakia can regress spontaneously without any intervention in 
habit or by any other means in about 40% of cases.  Significantly higher 
rates of regression is seen who discontinue the tobacco habit.  In one long 
term follow-up study among the Swedish population consisting 104 
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samples, they found that oral leukoplakia has disappeared in 43% of the 
people.  About 70-80% of leukoplakia is associated with tobacco habits, 
also about 80% of the leukoplakia lesions disappear completely about 58% 
or regress within 12 months after smoking cessation
. 22
 
Malignant transformation: 
It is generally accepted that dysplastic lesions carry a 5 fold greater 
risk than non dysplastic ones. It refers to the development of oral cancer 
from preexisting oral leukoplakia. So it is necessary to follow-up a case of 
leukoplakia for a period of 3 months to one year. 
2
 
            In the period of follow-up, the lesion should be evaluated for 
development of thickened/nodular areas, ulcerations, rolled margins, 
growths or indurated areas.  Since these changes represent early oral 
cancers.  Lesions on the tongue, lip vermilion border, floor of the mouth 
accounts for 93% of the leukoplakia with dysplastic changes or carcinoma. 
Globally 3-6% leukoplakia change to cancer.
23
 
Lee JJ, et al 
24
 conducted a study to find the relation between 
carcinoma and oral leukoplakia and demonstrated the results that some 
leukoplakias contain a malignant component. Lesions with certain features 
are more prone to carcinoma, but no clinical attributes can bring certainty in 
these lesions. 
Sol Silverman 
25
 made a follow up study on Oral leukoplakia and 
Malignant transformation in 257 patients for average period of 7.2 years 
.Seventy-three percent of the patients used tobacco, with cigarette usage 
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being the predominant form. Forty-five patients (17.5%) subsequently 
developed squamous carcinomas. High risks for malignant transformation 
also included non-smoking patients, the clinical presence of erythroplasia 
(erythroleukoplakia), and a clinical verrucous-papillary hyperkeratotic 
pattern. Duration of the leukoplakia progressively increased the total 
number of malignant transformations, with the largest rate occurring in the 
second year. This study confirms that oral leukoplakia is a precancerous 
lesion and that certain characteristics indicate greater risks and warrant 
consideration of more aggressive management.  
Non homogeneous leukoplakia accounted for the highest frequency 
of malignant transformation of 20%, whereas 3% of the homogeneous 
leukoplakia developed carcinoma.  Proliferative verrucous leukoplakia has a 
malignant transformation rate as high as 70.3% with mean follow-up of 
11.6% 
2
 
Differential diagnosis 
5
:  
The following differential diagnosis should be kept in mind whenever a 
clinical diagnosis of leukoplakia is made:  
 Acute pseudo membranous candidiasis or Thrush: White, curd-like 
or cotton like patches or plaques, most frequently occurring on the 
buccal mucosa and tongue, but also seen on the palate, floor of 
mouth and gingiva. They are usually associated with a burning 
sensation and the white plaque can usually be wiped away with 
gauze, leaving a tender, red area beneath, which may bleed. 
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 Reactive hyperkeratosis. A benign epithelial response, usually due to 
trauma from a fractured tooth or dental restoration. Check for the 
causative agent.  
 Leukedema :Usually bilateral, that disappears on stretching the 
mucosa 
 Lichen planus : Usually bilateral with lacy white pattern. 
 Lichenoid reaction: same like lichen planus; but positive history of 
drug intake, amalgam restoration, pan chewing habit. 
 Linea alba buccalis : Usually bilateral. The white line is present 
along the occlusal plane. 
Diagnosis : 
            Axell 
7
 suggested that diagnosis of leukoplakia can be arrived at by 
excluding lesions belonging to other entities, such as Lichen planus, Lupus 
erythematosus, Leukedema and White sponge nevus and lesions for which 
an etiology can be established, such as frictional keratosis, cheek/lip/tongue 
biting, contact lesions and smokers palate. 
           Pindborg 
8 
proposed that when there is a doubt in diagnosing 
leukoplakia,one can make a provisional diagnosis of leukoplakia and the 
definitive diagnosis can be established after the result of removal of any 
possible etiologic factors and a biopsy. 
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ORAL SUBMUCOUS FIBROSIS: 
Definition: 
The most widely accepted definition is by Pindborg J.J and Sirsat 
SM 
26. They have defined Oral submucous fibrosis as “An insiduous 
chronic disease affecting any part of oral cavity and sometimes the pharynx, 
although occasionally preceded by vesicle formation it is always associated 
with juxta –epithelial inflammatory reaction followed by a fibro elastic 
change of the lamina propria, with epithelial atrophy leading to stiffness of 
the oral mucosa and causing trismus and inability to eat.” 
Schwartz
26
 coined the term atrophica idiopathica mucosa oris to 
describe an oral fibrosing disease .He discovered in 5 Indian women from 
Kenya. 
 
Joshi 
26
 subsequently coined the term Oral sub mucous fibrosis 
(OSMF) for the condition. 
Historical Review:  
Oral submucous fibrosis has been well established in Indian medical 
literature since the time of Sushrutha renowned Indian Physician who lived 
in the era 2500-3000 B.C.
26
 
           Schwartz .J 
26 
first described Oral submucous fibrosis in modern 
literature among five East African women of Indian Origin under the term “ 
Atropica idiopathica mucosa oris”.  Since then this condition has been 
described by various investigators by various terms. 
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           Joshi S.G 
26
 described this condition in India when he reported 41 
cases with submucous fibrosis of the palate and it was he who suggested the 
use of the term “Oral submucous fibrosis’’.  
Lal. D 
26
 described it as a “Diffuse oral submucous fibrosis”,Joshi 
S.G in 1953 described it as “Sub mucous fibrosis of the palate and 
pillars”,Sui-Pin in 1954 described it as “Idiopathic scleroderma of the 
mouth”,Rao.A.B.N in 1962 termed it ias “Idiopathic palatal fibrosis”,Behl 
P.N in 1962 arrtibuted the term “Sclerosing stomatitis’’.  
Epidemiology: 
           Oral submucous fibrosis is an epidemic in India, and is prevalent 
throughout Indian sub continent,sparing no caste or creed, affecting the 
young and old ,the rich and poor alike.
9
 
           PindbordJ.J et al 
26
 reported that the prevalence of Oral submucous 
fibrosis in India ranges from 0.2-0.5%with a higher predominance in the 
southern part of the Indian subcontinent. 
Reports from Western India gives an incidence of 2.6 and 8.5 per 
1,00,000 per year for males and females respectively.  In South India it is 9 
and 20 per 1,00,000 per year for males and females respectively. 
            He stated that South Indian state of Kerala ,one new case could be 
expected per 10,000 populations per year.   The prevalence rate of oral 
submucous fibrosis in South Africa, Burma and India range from 0-1.2%. 
Gupta P.C et al 
10
 reported the incidence of Oral submucous 
fibrosis in Ernakulum ,India as 8 per 10,000 per men and 19 per 10,000 
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women per year.  In India Bhavnagar, in Western India the incidence was 
2.6 per 10,000 men and 8.15 per 10,000 women per year. 
About 2.5 million people are affected by this disease.  There is clear 
cut geographical predisposition to South East Asia. Most of these cases are 
found in India although cases have been reported in Taiwan, Malaysia, 
South Africa, New Guniea, Srilanka, Burma, United kingdom and Canada.
27   
    
Etiology: 
           The prime causes suspected on the basis of cause and effect 
relationship are prolonged and chronic use of arecanut, chillies, tobacco 
with arecanut, Pan masala, Pan, Vitamin B complex deficiency. 
           Arecanut chewing has the strongest evidence regarding the etiology.  
Arecanut is the endosperm of the fruit areca catechu tree, the fruit of which 
is orange yellow in colour when ripe 
28
.   
           A 10 year prospective study on 10,000 subjects showed a zero 
incidence of oral submucous fibrosis among those who did not chew 
arecanut compared with an incidence of 35 per 10,000 among arecanut 
chewers.
29
 
           It has been shown that arecanut and its extract mainly arecoline can 
stimulate fibroblast proliferation, collagen synthesis and increasing collagen 
cross linking in  invitro studies.  The flavinoids and tannins from betel nut 
can stabilize collagen and render them resistant to degradation by 
collagenase.
30
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         Maher R et al 
31
 conducted a case control study in Role of arecanut in 
the causation of Oral submucous fibrosis, Information on habits was 
collected by personal interview of 157 cases and 157 controls. Despite 
overall female preponderance, a substantial number of young men were 
enlisted. The male/female risks were found to be similar.  
No differences between risks were found when comparing the three 
age categories, 0-20, 21-40, 41-60 yr. Among the cases, an increased risk 
was observed for areca nut chewing. This habit when practiced alone 
appeared to have the highest risk (Relative Risk 154), followed by pan with 
or without tobacco (Relative Risk 64, 32 respectively). Logistic regression 
and discriminant analysis showed that daily consumption rates appeared to 
be more important with respect to risk than lifetime duration of habit.  
           Tobacco habits were more prevalent amongst those 15 cases who 
presented with concurrent carcinoma and OSMF. They concluded that areca 
nut chewing has a causal relationship with OSMF. Additional tobacco insult 
may be necessary for subsequent carcinoma development. 
           Rajendran.R 
30
 reviewed the etiology and pathogenesis of Oral 
submucous fibrosis.  According to him oral sub mucous fibrosis, a pre 
cancerous condition of the oral cavity has been studied by a number of 
workers in the field.  The available epidemiological data showed a clear cut 
geographical and ethnic pre dispositions, which suggested that certain 
customs or habits (chewing) prevalent among the population groups in 
South East Asia might be possible etiological factors.  However none of 
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these customs was shown to be casually linked.  This led some workers to 
consider the importance of systemic pre dispositions, in addition to the 
effects of local factors on the oral mucosa.  More research is needed to 
elucidate this problem.  
Murti.P.R. 
32
 reviewed the etiology of oral submucous fibrosis, a 
high risk pre cancerous condition, predominantly affecting Indians.  
Consumption of chilly was hypothesized as an etiologic factor on the basis 
of ecological observations and a solitary animal experimental study.  
Subsequent epidemiologic studies that included case-series reports, large 
cross-sectional surveys, case control studies, cohort and intervention studies 
have identified arecanut as the major etiologic factor.  Currently the role of 
genetic susceptibility and that of autoimmunity are receiving attention.  
Influence of nutritional factors if any remains unclear.     
      Shah N et al 
33  
conducted a study to identify the role of chewing and 
smoking habit in the etiology of oral submucous fibrosis. In this study 236 
cases of oral submucous fibrosis were compared with 221 control subjects 
matched for age, sex and socioeconomic conditions. It was found that 
chewing of areca nut, quid and pan masala was directly related to oral 
submucous fibrosis and not a single case was found without any chewing 
habit.  
The study showed that the pan masala chewers develop oral 
submucous fibrosis in half the time taken by areca nut betel quid chewers. It 
was also found that duration of chewing was not significantly correlated but 
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the frequency of chewing was directly correlated to manifestation of oral 
submucous fibrosis. 
Chung CH, et al 
34
 made a study to find the relation between Oral 
precancerous disorders  with areca quid chewing, smoking, and alcohol 
drinking in southern Taiwan and found of 1075 subjects,136  12.7%).  
Precancerous lesions and conditions were detected .The analysis of the 
spectrum of oral precancerous disorders detected, leukoplakia (n = 80), 
OSMF (n = 17) and verrucous lesions (n = 9), demonstrated an association 
with gender (P < 0.001). There were statistically significant associations 
among leukoplakia (P < 0.01), OSMF (P < 0.0001), and verrucous lesions 
The synergistic effect of smoking and areca quid chewing habit on 
leukoplakia and OSMF was demonstrated. Conclusion of this study 
reinforced the association of current areca quid chewing without tobacco, 
cigarette smoking, and alcohol drinking to leukoplakia, Oral submucous 
fibrosis, and verrucous lesions in Taiwan. 
Ranganathan K, et al  
35 
conducted a case control study in south 
India, over a 3 year period. A total of 185 consecutive patients with OSMF 
were matched with age- and sex-matched controls. History was recorded in 
a pre-determined format by qualified Dental Surgeons. The results obtained 
were, the male to female ratio of OSF cases was 9.9 : 1. All areca nut 
products were associated with OSF, with the risk being greatest for pan 
masala. The duration of the habit was more significant than the frequency of 
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the chewing habit. The present study confirms the strong association 
between areca nut use and OSF and the increasing use of pan masala 
 Punnya V. et al 
36
 made a a clinicopathologic  study of 205 cases in 
Indians. The study evaluated 205 cases of oral submucous fibrosis for the 
age, sex, site of involvement, duration of disease at the time of diagnosis, 
associated habits and common presenting symptoms, presence of other 
mucosal lesions, malignant potential, and the histopathology.  
The results revealed Oral submucous fibrosis seen in younger age 
(20–30 years) than that reported in literature and showed a characteristic 
male preponderance. A strong association with smokeless tobacco use 
especially arecanut in the form of gutkha was established and was related to 
earlier development of oral sub mucous fibrosis within a year of the habit. A 
total of 11.6% of cases were associated with malignancy and occurred 
predominantly in males. 
           Among systemic factors the main ones incriminated are chronic Iron, 
Vitamin B complex deficiency and anemia.  Iron metabolism is important in 
maintaining the health of oral mucosa as well as the epithelium of the 
digestive tract and it contributes to normal enzyme activity.
37
   
Clinical Features: 
Age : 
           There is no predilection for any age group however a broad age 
distribution with a peak in the range of 20-40 years was observed. 
10
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 Gupta PC, et al 
37 
conducted a study in India. A total of 11,262 men 
and 10,590 women aged 15 years and older were interviewed for their 
tobacco habits. Among 5018 men who reported the use of tobacco or areca 
nut, 164 were diagnosed as suffering from OSF. All but four cases were 
diagnosed among 1786 current areca nut users (age-adjusted relative risk: 
60.6). Areca nut was used mostly in mawa, a mixture of tobacco, lime and 
areca nut, and 10.9% of mawa users had OSF (age-adjusted relative risk: 
75.6). The disease as well as areca nut use was concentrated (about 85%) in 
the lower (< 35 years) age group. They concluded the study by depicting an 
increase in the prevalence of OSF, especially in the lower age groups, 
directly attributable to the use of areca nut products. This could lead to an 
increase in the incidence of oral cancer in the future.  
          Ahmad et al in 2006
38
 conducted an etiological and epidemiological 
study of oral submucous fibrosis in Patna, Bihar. Total 157 cases of OSMF 
and 135 control subjects were selected for study in the period of 2002-2004. 
It was observed that male: female ratio was 2.7: 1. The youngest case of 
OSMF was 11 year old and the oldest one was 54 years of age. Maximum 
numbers of cases were belonging to 21-40 years of age and they were 
belonging to low or middle socioeconomic class. Most of the OSMF cases 
used heavy spices and chillies, whereas control mild had spices and chillies. 
Gutkha was the most commonly used by the OSMF cases. Only 3 per cent 
did not use any gutkha or other areca nut product where as 80 per cent 
control did not have any chewing habit. The OSMF cases used gutkha and 
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other products 2-10 pouches per day and kept in the mouth for 2-10 minutes 
and they were using since 2-4 years. Most of the OSMF cases kept gutkha in 
the buccal vestibule or they chewed and swallowed it, only a small number 
of patients chewed and spitted it out. It was also observed that OSMF 
developed on one side of the buccal vestibule where they kept the chew and 
other side was normal. 
Gender : 
There is equal sex distribution, though some reports may vary 
indicating a female preponderance
.37
.  
            The major presenting complaint is progressive inability to open the 
mouth owing to the accumulation of inelastic fibrous tissue in the 
juxtaepithelial region of the oral mucosa.  Patients may describe a sudden 
onset of inflammation or ulceration of the oral mucosa and burning pain 
while eating highly seasoned food that previously caused no distress.
11
 
           The fibrosis also leads to difficulty in mastication speech and 
swallowing, pain in the throat and ears and relative loss of auditory acuity 
due to stenosis of the Eustachian tube.
 11
 
            In the early cases the fibrosis is seen arching from the anterior pillars 
in to the soft palate as a delicate reticulum of interlacing white strands 
which later become confluent.  In the cheeks a mottled marble like 
appearance may be seen when dense pale depigmented fibrosed areas 
alternate with pinker normal mucosa.
39
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           The floor of the mouth become pale and thickened, the tongue gets 
reduced in size and mobility, bands of encircling collagen distort lips.   
           At any stage in the disease the overlying epithelium may become the 
site of nonspecific ulceration, dysplastic change or malignant 
transformation.  If fibrosis extends in to the esophagus the patient may 
experience progressive dysphagia and reduced esophageal mobility.
38
 
           Patients with Oral sub mucous fibrosis often complains of sudden 
onset of inflammation or ulceration of oral mucosa with vesicle formation 
and increased sensitivity or burning sensation when eating spicy food that 
are followed by trismus, increasing difficulty in mastication speech and 
swallowing.
39 
           In advanced cases the jaws may be in separable and the total inelastic 
mucosa is forced against the buccal aspects of the teeth were sharp edges or 
restorations may cause ulcerations which become secondarily infected.  The 
fibrosis progress in to the posterior part of the buccal mucosa, the anterior 
pillar of fauces and the soft palate including uvula
.  38
   
Rajendran.R 
11
, reviewed the etiology, clinical features, 
epidemiology, pathology and management of Oral submucous fibrosis and 
concluded in his study as Oral submucous fibrosis is a chronic progressive, 
scaring disease that predominantly affects people of South East Asian 
origin.   
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Gupta P C and Dinesh Chandra  
40
 suggested the Clinical Grading  
as follows, 
The diagnosis of Oral submucous fibrosis is based on the positive 
history of areca nut chewing, Clinical and histopathological criteria.  The 
severity of the disease can be graded based on the clinical grading system. 
Grade I : 
           Presence of only blanching of oral mucosa without symptoms 
Grade II : 
           Presence of blanching and burning sensation, dryness mouth, vesicles 
or ulcers in the mouth. 
Grade III 
          Presence of blanching and burning sensation, dryness mouth, vesicles 
or ulcers in the mouth with restriction of mouth opening  
Grade IV :  
          Presence of blanching and burning sensation, dryness mouth, vesicles 
or ulcers in the mouth with restriction of mouth opening and palpable bands 
all over the mouth without tongue involvement.       
Grade V : 
           Presence of all features of Grade IV with tongue involvement. 
Grade VI : 
           Oral sub mucous fibrosis along with histopathologically proven 
carcinoma.            
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Malignant transformation:                   
           Paymaster 
26
 was the first one to mention the precancerous nature of 
Oral submucous fibrosis when he observed the development of slowly 
growing Squamous cell carcinoma in One third of his Oral submucous 
fibrosis patients. There is 3-19% malignant transformation in Oral sub 
mucous fibrosis.    
           Pindborg 
26 
reported that Oral submucous fibrosis patients in India 
have higher occurrence of leukoplakia and carcinomas than those without 
this disease. 
Murthi P.R et al  
32
 conducted a follow-up study of 66 patients over 
a 17-year period, and found cancer developed in 7.6% of patients. 
Pindborg 
8
 summarised the criteria in support of the precancerous 
nature of the disease as, 
1. Higher prevalence of leukoplakia among Oral submucous 
fibrosis patients. 
2. High frequency of epithelial dysplasia. 
3. Concurrent finding of Oral submucous fibrosis in oral cancer 
patients. 
4. Histological diagnosis of carcinoma without clinical suspicion of 
it and 
5. Incidence of oralcancer patients with oral submucous fibrosis. 
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Differential diagnosis 
41 
: 
1. Radiation induced fibrosis : which is confirmed by proper history 
taking regarding cancer history and radiation therapy.  
2. Scleroderma : which is detected by the clinical features of the 
disease like progressive sclerosis all over the body, including skin 
and internal organs. 
3. Fibrosis due to Actinomycosis infection  : Patients history reveals 
period of infection  and the treatment obtained. 
4. Fibrosis due to Trauma : patient history reveals history of trauma, 
surgery.            
ORAL SQUAMOUS CELL CARCINOMA 
Willis
42
 described neoplasm as an abnormal mass of tissue, the 
growth of which exceeds and is uncoordinated with that of normal tissue 
and persists in the same excessive manner after cessation of the stimuli 
which evoked the change.
 
The term oral cancer is used to describe any malignancy that arises 
from the oral tissues. Cancer is the second leading cause of death in United 
States. It is the sixth most common cancer in world wide. Oral cancer is 
more common than leukemia, lymphoma, cancer of stomach, ovary. More 
than 90-95%of the Oropharyngeal cancers are Squamous cell 
carcinoma
23
.The other 10% are salivary gland tumours, lymphomas, 
sarcomas. Oral cancer has been reported at higher rate in India, Southeast 
Asia , Hungary, France. Lesions which are likely to turn into oral cancer 
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include Leukoplakia, Oral submucous fibrosis, Erosive lichen planus. OSCC 
is the most common malignant neoplasm of the oral cavity. It can occur at 
any intraoral site but certain areas are most commonly involved. 
DEMOGRAPHICAL REVIEW 
Cancer is one of the major threats to public health in the developed 
world and increasingly in the developing world. In developed countries 
cancer is the second most common cause of death. According to the World 
Health Report 2004, cancer accounted for 7.1 million deaths in 2003 and it 
is estimated the overall number of new cases will rise by 50% in the next 20 
years.
43 
           
 
The prevalence of oral cancer is particularly high among men; oral 
cancer is the eighth most common cancer worldwide. Incidence rates for 
oral cancer vary in men from 1 to 10 cases per 100 000 population in many 
countries. In south-central Asia, cancer of the oral cavity ranks among the 
three most common types of cancer. In India, the age standardized incidence 
rate of oral cancer is 12.6 per 100 000 population.
44 
           In the South Asian region over one-third of tobacco consumed is 
smokeless. Traditional forms like betel quid, tobacco with lime and tobacco 
tooth powder are, commonly used and the use of new products is increasing, 
not only among men but also among children, teenagers, women of 
reproductive age, medical and dental students. In India, where chewing 
tobacco is used with betel nuts and reverse smoking (placing the lit end in 
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the mouth) is practiced, there is a striking incidence of oral cancer- these 
cases account for as many as 50% of all cancers.
43 
           India has the highest rate of oral cancer in the world, caused by 
tobacco consumption. WHO research indicates a 500 percent increase in 
cancer by 2025, of which 220 will be due to tobacco use. According to 
Women's Health in South East Asia (WHOSEA), almost one-half of all 
cancer cases in men and one-quarter of all cancer cases in women in India 
are believed to be tobacco-related.
43
  
Salonen et al 
45 
reported on occurrence of oral mucosal lesions and 
the influence of tobacco habits in a randomly selected adult Swedish 
population. Nine hundred twenty (920, 95%) of the selected samples of 967 
subjects comprising approximately 0.75% of the total adult population were 
examined; lesions were registered in 596 of the 920. The relationship 
between tobacco habits and mucosal lesions was analyzed and the time 
needed for treatment for the lesions was estimated. A positive correlation 
could be demonstrated between tobacco use and leukoplakia, frictional 
white lesion, coated tongue, hairy tongue and excessive melanin 
pigmentation, while a negative correlation was observed for geographic 
tongue and aphthous ulcer. 
Sankaranarayanan 
46
 found that oral cancer ranks number one 
among all cancers in male patients and number three among cancers in 
female patients. Causal association between oral cancer and the chewing of 
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betel quid containing tobacco leaves or stem and other tobacco habits has 
been extensively established. 
           Chakrabarti et al 
47
 in a Calcutta population compared the 
prevalence of oral carcinoma and dysplasia in smokeless tobacco users and 
non-users. A total of 3205 subjects were studied. Of the smokeless tobacco 
users, 1.96% had oral carcinoma compared with 0.36% of non-users. The 
prevalence of oral dysplasia in the user's group was 14.4% as compared with 
6.85% in the group of non-users. 
           Warnakulasurya 
48
 reviewed the data on smoking and chewing 
habits that were prevalent in the rural population of SriLanka and provided 
an assessment of the risk from these habits for oral pre cancer. According to 
one study among 1133 villagers, 54% men, and 42% woman chewed betel 
quid out of which 46% of men and 63% of women  included tobacco. 
Tobacco was chewed alone by 2.6%. A community based case control study 
conducted on oral precancerous lesion and condition in a screening camp 
included 359 patients (316 men and 43 women) aged over 20 years in whom 
the lesion was diagnosed and equal number of age and sex matched controls 
were included. The relative lowest risk of 5.3 among men and 5 women 
were observed among chewers of betel quid without tobacco and were not 
significant. When the quid was chewed with tobacco the relative risk was 15 
for men and 33 for women. Men who chewed betel quid with tobacco 
carried a higher risk than smokers (15 and 9.7 respectively). However a 
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higher relative risk of 24.7 was seen among men who both smoked and 
chewed indicating a synergistic action.       
Prabhu SR et al 
49 
stated that oral cancer is currently the most 
frequent cause of cancer related death among Indian men, which is usually 
preceded by oral pre cancerous lesion like leukoplakia or condition like oral 
sub mucous fibrosis. 
          Crispian Scully et al 
50
 stated that the etiological factors of oral 
cancer  include tobacco use 75% of people with oral cancer
 
smoke, betel use 
which includes Bidi leaf, and often tobacco, plus spices,
 
slaked lime, and 
areca nut, alcohol consumption, a diet poor
 
in fresh fruit and vegetables, 
infective agents 
 
immune deficiency, and in the case of lip carcinoma 
exposure
 
to sunlight. 
Jeng et al 
51
 stated that betel quid chewing is widely prevalent oral 
habit in India, Taiwan, Papua New Guinea, South Asia, and South Africa. It 
has been estimated that 600 million people chew betel quid worldwide. An 
average of 15 to 20 quid had been chewed by the betel quid users daily. A 
casual link between betel quid chewing and oral diseases such as oral 
leukoplakia, oral submucous fibrosis and oral cancer had been strongly 
established. 
Zain et al 
52
 stated about the role of tobacco smoking, chewing of 
tobacco, areca nut, and betel quid and drinking of alcohol are established 
cultural risk factors of oral pre-cancer and oral cancer worldwide. A 
geographic and regional variation in the prevalence of oral pre-cancer and 
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oral cancer indicates that the socio cultural life style plays an important role 
in the etiology and pathogenesis of the disease. 
Mehrota et al 
53
 stated that oral cancer was the commonest 
malignancy in Allahabad and the habit of chewing was particularly high 
among the oral cancer patients. The buccal mucosa was the most common 
site of oral cancer.  
Sinha 
54 
stated that oral use of smokeless tobacco is widely prevalent 
in the South East Asia Region; the different forms include chewing, sucking 
and applying tobacco preparations to the teeth and gums. In Southeast Asia 
over 250 million people use Smokeless tobacco products; about 17% of total 
population in Southeast Asia uses oral tobacco; of which 95% belong to 
India 82% and Bangladesh 13%. The global youth tobacco survey revealed 
high 10-20% prevalence of smokeless tobacco use among young students of 
age 13-15 year in Southeast Asia. Among disadvantaged youth group high 
45%-71% prevalence of tobacco use was reported in Southeast Asia. 
Tobacco is chewed in multiple forms in Southeast Asia, betel quid, leaf 
alone, leaf with lime and tobacco and areca nut preparation and tobacco 
water. Smokeless tobacco use varied from 7.2% to 59.4% in different states 
of India. In J & K, Goa, Himachal Pradesh, Haryana, Punjab, Kerala, 
Andhra Pradesh, Tamil Nadu, Delhi, Karnataka, Meghalaya, Rajasthan and 
West Bengal smoking prevailed over smokeless tobacco use while in 
Maharashtra, Uttar Pradesh, Sikkim, Madhya Pradesh, Assam, Orissa, 
Bihar, and Arunachal Pradesh smokeless tobacco use prevailed over 
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smoking. In Gujarat, Manipur and Mizoram proportion of smoking and 
smokeless tobacco use, among males was almost equal 28.3 years. 29.4 
while among female proportion was 5:1 12.4% years. 2.5 in rural and urban 
areas respectively. 
Warnukulasurya 
55
 reviewed different types of smokeless tobacco 
habits all around the world and its role in occurrence of oral cancer. There 
are two main types of smokeless tobacco , chewing tobacco and snuff. It 
may be used alone or in combination with other substances. Chewing 
tobacco comes in various forms, loose leaf, plug or twist. Loose leaf or dry 
powdered tobacco is often mixed with various ingredients according to the 
local custom. Snuff is commercially made in many different forms from fine 
cut or ground tobacco and can be dry or moist. Moist snuff is marketed as 
loose snuff in containers or as sachets . Many forms of ST are carcinogenic 
to humans and in animal studies. Cancer development at the site of 
placement and other oral mucosal lesions caused by these products has been 
described from several population groups.   
Durazzo et al 
56
 performed a study in Brazil on 374 patients with 
oral squamous cell carcinoma. Their ages varied from 14 to 94 years with 
mean = 57.4 years, with 255 men 68.2%, and 295 out of 366 Caucasian 
80.6%. A majority had tumours of the tongue and or floor of mouth 55.6%, 
while 20.3% had lip cancer. Squamous cell carcinoma was found in 90.3%, 
and glandular carcinoma in 4%, T4 tumours in 39.6%, T1 lesions in 15.2% 
of all patients. Nearly 62% had no regional metastases, and the relative 
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incidence in young patients 40 years or younger reached 8.6%, and 
concluded that in spite of the predominance of locally advanced tumours, a 
majority of patients had no neck metastases. The 31.8% incidence in 
females indicates an increasing incidence of oral cavity cancer among 
women when compared to previous periods at the same institution. 
Neufeild 
57 
 and his co workers conducted a survey in India between 
1995-96 constituting 4, 71,143 subjects and stated that the prevalence of 
alcohol consumption was present in 4.5%, smoking of tobacco was present 
in 16.2% and chewing of tobacco was present in 14% of the study subjects. 
The prevalence of these habits was found to be more common among men 
and among the rural population with no formal education. 
Mathew et al 
58
 studied total of 1190 subjects who visited the 
department of oral medicine and radiology for diagnosis of various oral 
complaints over a period of 3 months were interviewed and clinically 
examined for oral mucosal lesions. The result showed the presence of one or 
more mucosal lesions in 41.2% of the population. Fordyce's granules was 
observed most frequently 6.55% followed by frictional keratosis 5.79%, 
fissured tongue 5.71%, leukoedema 3.78%, smoker's palate 2.77%, 
recurrent aphthae, oral submucous fibrosis 2.01%, oral malignancies 1.76%, 
leukoplakia 1.59%, median rhomboid glossitis 1.50%, candidiasis 1.3%, 
lichen planus 1.20%, varices 1.17%, traumatic ulcer and oral hairy 
leukoplakia 1.008%, denture stomatitis, geographic tongue, betel chewer's 
mucosa and irritational fibroma 0.84%, herpes labialis, angular cheilitis 
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0.58%, and mucocele 0.16%. Mucosal lesions like tobacco-related lesions 
leukoplakia, smoker's palate, oral submucous fibrosis, and oral malignancies 
were more prevalent among men than among women. Denture stomatitis, 
herpes labialis, and angular cheilitis occurred more frequently in the female 
population.  
 LIPIDS 
          Lipids are the heterogenous group of compounds related to the fatty 
acids. They are insoluble in water and soluble in other solvents such as 
Ether, Chloroform and Benzene. They are chemically the esters of fatty 
acids and some alcohol. Lipids occur widely in plants and animal kingdom. 
It includes fats, oils, waxes and related compounds. Oils are liquid at 20°C 
but fats are solid at this temperature. In the body, fat serves as an efficient 
source of energy when stored in an adipose tissue. The fat soluble vitamins 
and the essential fatty acids are found with the fat of natural foods. It serves 
as an insulating material in the subcutaneous tissues and around certain 
organs. Lipoproteins are combination of fat and protein and glycolipids are 
combination of fat and carbohydrates. Both are essential for maintaining 
cellular integrity. They provide building blocks for different molecular 
weight substances like acetic acid and can be used for the synthesis of 
cholesterol and certain hormones. They produce metabolites through 
oxidation in the tissues which are used in the conversion of substances. 
           Williams et al 
59
 conducted a study on 5,209 patients in Framingham 
for 24 years, in which 691 cases of cancer were documented with 
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histological confirmation and were tested for associations with occurrence 
of cancer in patients with low serum cholesterol. It was found that that 
Serum cholesterol level was inversely associated with incidence of colon 
cancer with p=0.01 and with other sites only in men; these inverse 
associations were statistically significant after adjustment for age, alcohol 
consumption, systolic blood pressure, and relative weight.  
            Kark et al 
60 
conducted a study on 3102 people in Evans which were 
followed for over 12-14 years to assess the incidence of cancer and serum 
cholesterol and there was an inverse association between incidence of 
cancer and  serum retinol and serum cholesterol concentrations with p-value 
of 0.05 and 0.002 respectively. 
 Vitols et al 
61 
conducted a study on 59 patients with acute leukaemia 
were examined to see if hypocholesterolaemia, which is commonly found in 
acute leukaemia, was due to the high low-density-lipoprotein (LDL)-
receptor activity of leukaemic cells and the results showed  LDL-receptor 
activity was   inversely correlated with plasma-cholesterol concentration. 
 Richmond et al 
62
 did a study involving 10 subjects with a history of 
smoking and 10 controls, they measured cholesterol and TGL, HDL-3,             
HDL-2. They found that there is decrease in the concentration of HDL2 
cholesterol with p=0.043 and the ratio of HDL2 to HDL3 cholesterol with 
p=0.02 is observed in smokers when compared to non-smokers 
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 Alexopoulos et al 
4
  conducted a study on 103 cancer patients (60 
men and 43 women; mean age, 56 years) and 100 age-matched non cancer 
patients to assess the total serum cholesterol, free and esterified cholesterol, 
high-density lipoprotein (HDL) and low-density lipoprotein (LDL) 
cholesterol, serum triglycerides. The results showed Cancer patients as a 
group demonstrated significantly lower total cholesterol with P < 0.02, 
esterified cholesterol  with P < 0.05  and LDL cholesterol with P < 0.05 
compared with non cancer patients.  
                Arthur et al 
63
 did a cohort study for 10 years to evaluate relation 
of total serum cholesterol to all cancer and site-specific cancer incidence in 
459 male cancer patients and 398 female cancer patients. There was an 
inverse association between cholesterol and all cancer; lung, colorectal, 
pancreatic, and bladder cancers with P = 0.02 ,P = 0.5, P = 0.02, P = 0.23 
respectively. They also found that the inverse association was present 
between serum cholesterol for smoking-related cancers diagnosed. 
           Larry 
64
 conducted a study to determine the extent to which regular 
use of smokeless tobacco is associated with hypercholesterolemia among 
2,840 adult males. Individuals with smokeless tobacco users were 2.5 times, 
heavy smokers were 2 times and mild/moderate smokers were 1.5 times 
more likely to have hypercholesterolemia than non-users of tobacco. There 
were no differences in risk of hypercholesterolemia between the smokeless 
tobacco and cigarette smoking groups. It was concluded that the present 
findings that the consequences of using smokeless tobacco may reach 
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beyond the oral cavity which may lead to cardiovascular disease, as well as 
leukoplakias and oral cancer.  
 Pugalendi et al 
65
 evaluated the blood cholesterol and HDL 
cholesterol in 24 cigarette smokers, who were compared with age and sex 
matched controls. They found that elevated total cholesterol in smokers and 
significant decrease of HDL cholesterol.  
            Whig et al 
66
 conducted a study which measured Serum lipids and 
lipoproteins of 50 active and passive smokers were compared with levels in 
25 control subjects where they found active smoking resulted in an increase 
in total cholesterol and triglycerides as compared to control group. The 
passive smokers also showed relatively higher levels but the effect was not 
significant. Active smoking raised the low density lipoprotein cholesterol 
and very low density lipoprotein cholesterol levels whereas high density 
lipoprotein cholesterol content was lowered, thus resulting in decreased 
ratios of HDL/Tc and HDL/LDL. The passive smokers also showed slightly 
higher levels of LDL and VLDL but lower levels of HDL, and a lower 
HDL/LDL ratio. Their findings suggest that smoking alters the serum lipids 
and lipoproteins and these changes are related to the duration and amount of 
smoking. 
              Manoharan et al 
67
 evaluated the role of life-style on plasma and 
erythrocyte membrane lipid profile in 25 adult male gastric cancer patients 
as well as age and sex-matched controls. Total, free and LDH cholesterol 
were markedly elevated in plasma and erythrocyte membrane whereas HDL 
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cholesterol and triglycerides were significantly reduced in gastric cancer 
patients. These changes can be attributed to alcohol consumption and 
cigarette smoking-risk factors in gastric carcinogenesis, associated with low 
levels of ascorbic acid and vitamin E. 
              Neufeld et al 
68 
conducted a cross-sectional, pilot-scale study to 
examined the relationship of HDL cholesterol levels to passive
 
smoking in 
children and adolescents. HDL cholesterol levels were 38.7±1.2
 
mg/dL 
(mean±SEM) in passive smokers versus 43.6±1.2
 
mg/dL in children without 
smoke exposure (P=.005). They found that mean HDL cholesterol levels 
were significantly
 
lower in hyperlipidemic children who came from 
households with
 
smokers compared with those from nonsmoking 
households. The results of this small-scale study suggest that interventions
 
resulting in decreased cigarette exposure may substantially
 
increase HDL 
cholesterol levels in this group of patients at
 
higher risk for premature 
cardiovascular disease. 
               Vural et al 
69 
conducted a study involving 13 patients with Actinic 
Keratosis and 12 patients with Basal Cell Carcinoma to evaluate the serum 
Cholesterol, phospholipid, triglyceride, and total lipid levels. They found 
that the levels of all lipid fractions were increased in both Actinic chelitis 
and Basal cell carcinoma. A significant increase in phospholipids and total 
lipids with p < 0.02,  p < 0.01 respectively  was found in BCC. Serum 
cholesterol with p < 0.001, phospholipid  with p < 0.001), triglyceride with 
p < 0.05, and total lipid with p < 0.001 concentrations of AK patients were 
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significantly higher than those of the control group. When BCC and controls 
were compared, a significant increase in phospholipids and total lipids with 
p < 0.001 was seen. Serum cholesterol in BCC patients was significantly 
lower  with p < 0.001 and serum phospholipid levels were significantly 
higher with p < 0.05 than those in the AK group. They concluded that an 
increase in the metabolically active serum phospholipid fraction contributed 
to the elevated neoplastic tissue phospholipid. This produced altered 
proportions between lipid fractions in tumorous areas and resulted in 
changes in the intact nature of the cellular membrane, spread, and malignant 
proliferation. 
         Khurana et al 
70 
conducted a study   on Serum lipid profile of 30 
smokers, 30 tobacco chewers and 30 controls to evaluate lipid profile in 
cigarette smokers and tobacco chewers and to see whether tobacco chewing 
causes same degree of alteration in lipid profile as done by smoking and 
found that High density lipoprotein-cholesterol was lower both in smoker (P 
< 0.01)  as well as in tobacco chewers (P < 0.001) than the controls. Both 
smokers and tobacco chewers had higher values of total cholesterol, low 
density lipoprotein cholesterol, very low density lipoprotein-cholesterol and, 
triglycerides as compared to non-smoker, non-tobacco chewer group 
whereas the differences in levels of lipids in smokers and tobacco chewers 
were not statistically significant. 
           Raste et al 
71
 conducted a study to examine the lipid profile in 
normal healthy age matched control and patients with various malignancies. 
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They found that total lipids, cholesterol and HDL cholesterol levels with 
p<.001 are inversely associated with incidence of cancer where as 
triglycerides levels were significantly elevated with p>.01 in cancer patients.  
              Neki 
72 
conducted a study to evaluate lipid profile in young 
cigarette/bidi smokers and compare it with non smokers in the fasting state 
on 50 healthy cigarettes smokers and compared with 50 healthy age and 
weight matched non-obese non-smokers who served as controls. It was 
revealed that mean TC,LDL , and VLDL were significantly higher in 
smokers  with p <0.05 as compared to non-smokers. Mean serum TG levels 
in smokers were significantly high with (p <0.01 as compared to non-
smokers. Mean serum HDLC was significantly lower with p <0.01 in 
chronic smokers as compared to non-smokers. He concluded that smoking 
produces adverse effects on lipid profile, therefore increasing the 
cardiovascular disease risk 
           Patel et al 
5  
conducted a  case control study on 184 head and neck 
cancer patients, 153 patients with Oral precancerous conditions  and 52 
controls and their Plasma lipids including  Total cholesterol, LDL ,HDL , 
VLDL  and  triglycerides were analysed  and found  a  significant decrease 
in plasma total cholesterol and HDLC was observed in cancer patient 
P=0.008 and P=0.000 respectively as well as in patients with OPC P=0.014 
and P=0.000 
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              Manoharan et al 
73
 conducted a study to assess the level of 
oxidative stress in oral cancer patients with various clinical stages. Level of 
lipid peroxidation and antioxidants in oral cancer patients were studied. 
They found that the elevated lipid peroxidation and decline in non-
enzymatic and enzymatic antioxidants status were noticed in oral cancer 
patients as compared to healthy subjects. They concluded that altered lipid 
peroxidation in plasma and erythrocytes of oral cancer patients may be 
related to their compensatory changes in the antioxidants defense system. 
            Barcin et al 
74
 conducted a study to the effects of non-heavy 
smoking < or =20 cigarettes a day on HDL-c in 1012 male students between 
19 and 25 years old. They found that HDL-c with p<0.001 showed a 
stepwise decrease as the level of smoking increased. Total cholesterol, 
triglycerides and low-density cholesterol were not different among the 
smoking levels. Body mass index (BMI) and waist/hip ratio were found to 
be slightly decreased in smokers with p < 0.001.They concluded that 
smoking, even in relatively low levels, has a negative stepwise relationship 
with HDL-c in a homogeneous population of healthy young men in whom 
other major non-genetic factors that are known to affect HDL-c levels are 
identical. 
        Venkatesan et al 
75
 conducted a study to to assess the association 
between smoking and the alteration in plasma concentration of lipid profile 
and lipid peroxides in fourteen smokers and 11 age matched control group. 
Plasma levels of fasting cholesterol, triglycerides, lipoprotein cholesterol 
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and malondialdehyde were estimated. They found that in smokers the levels 
of total cholesterol p=0.021, LDL cholesterol p=0.006, Non-HDL 
cholesterol p= 0.016 and MDA p=0.001 were significantly elevated when 
compared with the controls. 
           Lim et al 
76 
conducted a study to investigate the relationship between 
prediagnostic HDL-C and non-Hodgkin lymphoma (NHL) in 27,074 healthy 
male smokers of ages 50 to 69 years. They found that there is an inverse 
association between HDL-C and NHL with P < 0.0001. They concluded that 
HDL-C as a preclinical indicator of NHL . 
              Patel et al 
77 
conducted a study to monitor oxidative stress and 
predict overall survival in oral cancer patients by estimating markers of 
oxidative stress such as total antioxidant status, lipid peroxidation, and total 
thiol levels in 140 oral cancer patients and 50 healthy controls, who were 
classified as with the habit of tobacco and no habit of tobacco. They found 
that Thiol levels were significantly lower in controls with the habit of 
tobacco P= .033, oral cancer patients P= .0001, and malignant tissues P= 
.015 as compared to controls with no habit of tobacco, controls with the 
habit of tobacco, and adjacent normal tissues, respectively. They concluded 
that lipid peroxidation and thiol could be useful for predicting the risk of 
oral carcinogenesis in healthy tobacco consumers and predicting overall 
survival of oral cancer patients. 
               Wakabayashi 
78 
conducted a study to determine whether 
influences of drinking alcohol on serum lipid levels are different in smokers 
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and non-smokers in 25,689 healthy male patients. Serum total cholesterol, 
HDL, triglyceride concentrations and LDL cholesterol concentrations were 
estimated. He found that in the smoker groups, serum total cholesterol was 
significantly lower in heavy drinkers than in non-drinkers, while no 
difference in total cholesterol was observed in non- and heavy drinkers of 
the non-smoker group. Both in the smoker and non-smoker groups, HDL 
cholesterol was higher with P < 0.01 and LDL cholesterol was lower in 
drinkers than in non-drinkers. He concluded that smoking increases the 
lowering effect of alcohol drinking on LDL cholesterol, but does not affect 
the relationship of alcohol drinking with HDL cholesterol. 
          Lohe et al 
3 
conducted a study on 210 patients with 70 in oral cancer, 
oral precancer and 70 control group  to evaluate and correlate the decreased 
cholesterol levels in oral cancer, oral precancer. They found a significant 
decrease in TC ,HDL,VLDL and Triglyceride in Oral cancer group with 
p<.001 and significant decrease in TC,HDL  with p<.001 in oral precancer 
as compared to control group. They concluded that there is an inverse 
relationship between serum lipid profile and oral cancer, oral precancer. 
 Nayak et al 
79
 conducted a study on 56 subjects with the study group 
consisting of a total of 28 patients 14 with OFS and 14 with LP to evaluate 
changes in plasma lipid profile in patients with oral precancerous conditions 
and to evaluate if any relation exists between the plasma lipid level and 
malignant potential. They found that TC, HDL, LDL TC, HDL, and LDL (p 
< 0.05), were reduced in Oral Precancerous patients. They concluded that 
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TC, HDL, LDL of lipid profile were reduced in OPC patients .Reduced lipid 
values in plasma may be due to greater utilization of lipids for new 
membrane biogenesis. 
 Chawda et al 
80 
conducted a study to investigate the alterations and 
clinical significance of plasma lipid profiles in untreated head and neck 
cancer patients in 30 subjects .They found that the levels of total lipids, 
cholesterol and HDL with p<0.005 were significantly lower in oral cancer 
patients as compared to controls, but LDL and VLDL values were not 
significant. They concluded that an inverse relationship was found between 
the lipid levels and the occurrence of oral cancer.  
            Shally et al 
81
conducted a study on 25 patients of oral squamous cell 
Carcinoma, 15 patients each of OSMF, leukoplakia, and lichen planus and 
15 healthy controls to evaluate the alterations in extended lipid profile . A 
significant decrease in plasma total cholesterol, HDLC, and triglycerides 
with p<.001 was observed in the patients with the precancerous lesions and 
conditions as compared to the controls. Thus, an inverse relationship 
between plasma lipid levels and patients was found Hence, the lower plasma 
lipid status may be a useful indicator to detect the initial changes seen in 
neoplastic process. 
Materials and Methods 
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 This is a cross sectional hospital based study conducted between 
from March 2010 to March 2011 which was designed to estimate the lipid 
profile in serum in patients with Potentially Malignant diseases namely Oral 
Leukoplakia and Oral Submucous fibrosis and Oral Squamous cell 
carcinoma in the Department of Oral Medicine and Radiology of Ragas 
Dental College and Hospital, Uthandi, Chennai. 
Study design:   
The present study is a Case Control Study. 
Study population:  
Study population includes all subjects reporting to Ragas Dental 
College and Hospital, Outpatient Department, Uthandi seeking dental 
advice and who are from a wide variety of socioeconomic background. The 
age group selected was between 20-60 years. 
Study sample: 
A total number of 75 patients were involved in the study. 
a. Normal controls-Group-I : 25   
b. Patients with Oral Potentially malignant disorders-Group-II : 25 
c. Patients with Oral Squamous cell carcinoma–Group-III: 25 
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Obtaining approval from the authorities: 
Permission from the ethical committee of Ragas Dental College and 
Hospital, Chennai was obtained before starting the study for interpretation 
and examining subjects, for drawing 5ml of  blood . 
Also an informed consent was obtained from the subjects forming 
the study sample, both in English and Tamil to participate in the study and 
to undergo blood investigation in the course of study. 
Selection Criteria: 
For Normal controls  
 This study group I consists of 25 patients. These patients were 
selected from the Department of Oral Medicine and Radiology. 
 Inclusion criteria : 
Routine intra oral examination was carried out on all subjects 
reporting to Ragas Dental College and Hospital, Chennai and during soft 
tissue examination thorough examination was carried out to rule out any 
mucosal  lesions which is in consistent with the diagnosis of leukoplakia 
and Oral submucous fibrosis.  
Exclusion Criteria : 
1. Subjects with major systemic ailments with cardiovascular, 
respiratory diseases were excluded. 
2. Subjects with any form of immunosupression and with autoimmune 
disorders were excluded  
Subjects with history of corticosteroid therapy were excluded 
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Oral Potentially malignant disorders   
       This study group II consists of 25 patients suffering from Oral 
Potentially malignant disorders like Oral Leukoplakia and Oral Submucous 
fibrosis diagnosed clinically. These patients were selected from the 
Department of Oral Medicine and Radiology. 
LEUKOPLAKIA: 
Inclusion Criteria: 
Routine intra oral examination was carried out on all subjects 
reporting to Ragas Dental College and Hospital ,Chennai and subjects with 
positive history of smoking tobacco and during soft tissue examination, 
subjects with well-defined white patch, localized or extensive, that is 
slightly elevated and that has a fissured, wrinkled or corrugated surface or a 
mixed red – white lesion in which keratotic white nodules or patches are 
distributed over an atropic erythematous background or presence of thick 
white lesions with papillary surfaces in the oral cavity and on palpation 
which reveals leathery consistency and which is in consistant with the 
diagnosis of leukoplakia were taken for the study. 
Exclusion Criteria : 
1. Lesions belonging to other entities such as Lichen planus, lupus 
erythematosus, leukedema and white sponge nevus and lesions for 
which etiology can be established, such as frictional keratosis, 
cheek/lip/tongue biting, contact lesions and stomatis nicotina 
palatini. 
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2. Subjects with major systemic ailments with cardiovascular, 
respiratory diseases were excluded. 
3. Subjects with any form of immunosupression and with autoimmune 
disorders were excluded 
4. Subjects with history of corticosteroid therapy were excluded. 
For subjects with Oral Submucous fibrosis: 
Inclusion criteria: 
Routine intra oral examination was carried out on all subjects 
reporting to Ragas Dental College and Hospital, Chennai ,subjects with  
positive history of arecanut chewing and  during soft tissue examination 
clinical features like blanching of oral mucosa, burning sensation, dryness 
of mouth, vesicles or ulcers in the mouth ,restriction of mouth opening, 
palpable fibrotic bands in any area of the mouth with smooth and bald 
tongue with   limited tongue movement  and which is in consistent with the 
diagnosis of Oral submucous fibrosis were taken for the study. 
Exclusion criteria : 
1. Fibrosis due to radiation therapy, scleroderma, post Actinomycosis 
healing fibrosis, fibrosis due to trauma, surgery were excluded by 
taking proper case history and if positive history was present, they 
were excluded from the study. 
2. Subjects with major systemic ailments with cardiovascular, 
respiratory diseases were excluded. 
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3. Subjects with any form of immunosupression and with autoimmune 
disorders were excluded 
4. Subjects with history of corticosteroid therapy were excluded 
Oral Cancer 
 This study group III consists of 25 patients suffering from oral 
cancer diagnosed clinically. These patients were selected from the 
Department of Oral Medicine and Radiology, Dr.Rai Memorial Medical and 
Cancer center and Cancer shelter. Clinical Selection Criteria: 
 Presence of a non – healing ulcer proliferative growth with pain, 
tenderness, limitation / loss of function, bleeding and indurated margins. 
Presence of regional lymphadenopathy 
MATERIALS  
Examination of the patient 
 Conventional Dental chair with illumination facility with halogen 
lamp. 
 A pair of sterile gloves. 
 Disposable mouth mask. 
 Stainless steel Kidney trays. 
 Dental Plain mouth mirror, Dental straight probe, tweezer. 
 Sterile gauze pieces and cotton. 
 Glass tumbler with water. 
 0.2% chlorhexidine gluconate. 
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 Sterilizer, cheatel forceps. 
Collection of blood sample: 
 24 gauge needle and 5ml plastic syringe  
 Vacutainer coated with Ethylene diamine tetra acetic acid (EDTA) 
 Torniquet 
 Sterile Cotton 
 70% alcohol as surface disinfectant 
 Sterile vials 
 Refrigerator 
Equipments: 
 Centrifuge for separating plasma from blood 
 Shimadzu UV spectrophotometer 
 Micro pipette 
 The experimental subjects were made to sit comfortably on a dental 
chair. Relevant Demographic data and datas relevant to the habit of 
smoking, chewing, alcoholism were collected. Subjects were examined 
under halogen lamp .Sterile hand gloves were used during examination of 
the subjects. For subjects who showed characteristic features of Oral 
leukoplakia and Oral submucous fibrosis based on history and clinical 
features, clinical diagnosis was made by using the clinical grading system 
for each lesions separately. 
        For Oral Leukoplakia clinical diagnosis was made with the aid of 
classification and staging given by Pindborg et al in 1997. 
8
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Classification and staging of oral leukoplakia:   
Provisional (Clinical Diagnosis) 
L : Extent of leukoplakia 
          L0 : No evidence of lesion 
          L1 : ≤ 2 cm 
          L2 : 2-4 cm 
          L3 : ≥ 4cm 
S : Site of leukoplakia 
          S1 : all sites excluding floor of mouth & tongue 
          S2 : floor of mouth &/ tongue 
          S3 : not specified 
C : Clinical aspect 
           C1 : homogeneous 
           C2 : non homogeneous 
           C3 : not specified. 
 For Oral submucous fibrosis clinical diagnosis was made with the 
aid of clinical grading given by Gupta P C and Dinesh Chandra in 1992
40
  
Grade I : 
           Presence of only blanching of oral mucosa without symptoms, 
Grade II : 
           Presence of blanching and burning sensation, dryness mouth, vesicles 
or ulcers in the mouth. 
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Grade III : 
           Presence of blanching and burning sensation, dryness mouth, vesicles 
or ulcers in the mouth with restriction of mouth opening  
Grade IV :  
           Presence of blanching and burning sensation, dryness mouth, vesicles 
or ulcers in the mouth with restriction of mouth opening and palpable bands 
all over the mouth without tongue involvement.       
Grade V : 
           Presence of all features of Grade IV with tongue involvement. 
Grade VI : 
           Oral submucous fibrosis along with histopathologically proven 
carcinoma.          
 
For Oral squamous cell carcinoma , TNM staging is given according to 
AJCC 
Cancer Staging 2005 
82
 
T-SIZE OF THE TUMOUR 
 TX Primary tumor cannot be assessed. 
 T0 There is no evidence of primary tumor. 
 Tis Carcinoma is in situ. 
 T1 Tumor is 2 cm or less in greatest dimension. 
 T2 Tumor is more than 2 cm but not greater than 4 cm in greatest 
dimension. 
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 T3 Tumor is more than 4 cm in greatest dimension. 
 T4 (lip) Tumor invades through cortical bone, inferior alveolar 
nerve, floor of mouth, or skin of face, chin or nose. 
 T4a oral Tumor invades adjacent structures (e.g., through cavity) 
cortical bone, into deep [extrinsic] muscle of tongue, maxillary 
sinus, skin of face. 
 T4b Tumor invades masticator space, pterygoid plates, or skull base 
and/or encases the internal carotid artery 
N-NODE STATUS 
 NX Regional lymph nodes cannot be assessed. 
 N0 There is no regional nodes metastasis. 
 N1 Metastasis is in a single ipsilateral lymph node, 3 cm or less in 
greatest dimension. 
 N2 Metastasis is in a single ipsilateral lymph node, more than 3 cm 
but not more than 6 cm in greatest dimension; or metastasis is in 
multiple ipsilateral lymph nodes, none more that 6 cm in greatest 
dimension; or metastasis is in bilateral or contralateral  lymph nodes, 
none greater than 6 cm in greatest dimension. 
 N2a Metastasis is in a single ipsilateral lymph node, more than 3 cm 
but not more than 6 cm in greatest dimension. 
 N2b Metastasis is in multiple ipsilateral lymph nodes, none more 
that 6 cm in greatest dimension. 
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 N2c Metastasis is in bilateral or contralateral lymph nodes, none 
more than 6 cm in greatest dimension. 
 N3 Metastasis is in a lymph node more than 6 cm in greatest 
dimension 
M-Distant Metastasis  
 MX Distant metastasis cannot be assessed. 
 M0 There is no distant metastasis. 
 M1 There is distant metastasis 
Stage Grouping 
Stage 0  Tis N0 M0 
Stage I  T1 N0 M0 
Stage II  T2 N0 M0 
Stage III  T3 N0 M0 , T1 N1 M0 
             T2 N1 M0, T3 N1 M0 
Stage IVA  T4a N0 M0, T4a N1 M0 
             T1 N2 M0 , T2 N2 M0 
             T3 N2 M0, T4a N2 M0 
Stage IVB  T4b Any N M0 
            Any T N3 M0 
Stage IVC  Any T Any N M1 
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Blood sample collection: 
The patients arm was rested on the working table comfortably.  The 
anti cubital fossa was exposed and the tourniquet was applied above 1 ½ - 2 
inch above the anti cubital fossa.  The area was rendered aseptic with 70% 
alcohol and using 24 gauge needles and vacationer 5 ml of fasting blood 
was drawn, then the tourniquet was relieved and the needle was removed, 
simultaneously, a sterile cotton was placed on the needle puncture site and 
instructions were given to apply finger pressure for 5 minutes and dispose 
the cotton.  The collected blood was centrifuged, serum was separated and 
stored in vials. This freshly obtained serum was used immediately for 
biochemical analysis.   
BIOCHEMICAL ANALYSIS 
Estimation of serum lipid profile 
83 
 Total cholesterol: Serum cholesterol levels were estimated using 
cholesterol kits obtained from HiTech diagnostics, Chennai. 
Methodology: 
Principle: 
 The estimation of cholesterol involves the following enzyme 
catalysed reactions 
1. Cholesterol ester is converted into cholesterol and fatty acid in the 
presence of cholesterol esterase. 
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2. Cholesterol then combines with oxygen in the presence of 
cholesterol oxidase and forms cholest-4-en-3-one and hydrogen 
peroxide 
3. 2 molecules of H2O2 combines with 4 aminoantipyrine and phenol 
and forms 4 molecules of water and quinoeimine. absorbance of 
quinoeimine so fromed is directly proportional  to cholesterol 
concentration. 
Reagent composition 
Reagent 1 : cholesterol reagent 
cholesterol  esterase 200IU/L 
Cholesterol oxidase 150IU/L 
Peroxidase(horseradish) 2000IU/L 
Sodium phenolate 20mmol/L 
4 aminoantipyrine 0.5mmol/L 
Phosphate buffer 68mmol/L 
Lipid clearing agent  
 
Reagent 2: 
Cholesterol 200mg/dl 
5.2mol/l 
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Reagent 3: Double deionized ,0.2 micron,membrane filtered ,particle free 
water for reconstitution of reagent 1 
 Procedure : Reagents 1 and 3 are allowed to attain the room 
temperature. Aqua 4 is added on to the contents of each vial on the reagent 
1,swirled and dissolved. 
    A blank solution is prepared by adding 1000µl of reagent to 20µl of 
distilled water. A standard solution is prepared by adding 1000µl of reagent 
to 20µl of cholesterol standard. A test solution is prepared by adding 1000µl 
of reagent to 20µl of sample. Blank is aspirated followed by standard and 
tests. The mixture is shook well and incubated at 37
0
 c. The three solutions 
are read using the analyser. The blank is read first followed by standard and 
test solution. 
 High density lipoprotein: Serum High Density Lipoprotein levels 
were estimated using HDL Cholesterol  kits obtained from HiTech 
diagnostics,Chennai. 
Reagent 1: 
Phosphotungstic acid 2.4 mmol/L 
Magnesium chloride 40mmol/L 
 
Reagent 2: 
HDL cholesterol standard 25mg/dl 
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Reagent preparation: the reagent is ready for use. 
 Supernatant of sample is obtained by adding 500µl of precipitating 
reagent to 250µl of sample. Mixture is shook well and allowed to stand for 
10 minutes at room temperature. Then the mixture is centrifuged at 4000 
rpm for 10 minutes and clear Supernatant fluid is obtained which is used to 
determine the concentration of HDL cholesterol in the sample. 
 A blank solution is prepared by adding 1000µl of reagent to 50µl of 
distilled water. A standard solution is prepared by adding 1000µl of reagent 
to 50µl of  HDL cholesterol standard. A test solution is prepared by adding 
1000µl of reagent to 50µl of supernatant. The mixture is shook well and 
incubated at 37
0
 C. The three solutions are read using the analyser. The 
blank is read first followed by standard and test solution. 
 Triglyceride : Serum Triglyceride levels were estimated using HDL 
Cholesterol  kits obtained from HiTech diagnostics, Chennai. 
Reagent 1: 
Ingredient Concentration 
ATP 2.5mmol/L 
Mg 
2+
 2.5mmol/L 
4 aminoantipyrine 0.8mmol/L 
3,5 dichloro-2-hydroxybenzen 
sulfonate 
1mmol/L 
Peroxidase  2000IU/L 
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Glycerol kinase 550IU/L 
Glycerol phosphate oxidase 8000IU/L 
Lipoprotein lipase 3500IU/L 
Buffer 53mmol/L 
Reagent 2 : 
Triglyceride standard 200mg/dl 
 
 Procedure : Reagent bottles and aqua 4 are allowed to attain the 
room temperature. Aqua 4 is added on to the contents of each vial , swirled 
and allowed to stand for 10 minutes at room temperatue. 
 A blank solution is prepared by adding 1000µl of reagent to 10µl of 
distilled water. A standard solution is prepared by adding 1000µl of reagent 
to 10µl of triglyceride standard. A test solution is prepared by adding 
1000µl of reagent to 10µl of sample.The mixture is shook well and 
incubated at 37
0
 c. The three solutions are read using the analyser. The 
blank is read first followed by standard and test solution. 
Very lowdensity lipoprotein : calculated by the fomula  
 VLDL=Triglyceride/5 
Lowdensity lipoprotein : calculated by the fomula 
 LDL=Total clolesterol-(VLDL-HDL) 
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Normal values 
Parameter Normal serum concentration (mg%) 
Total cholesterol 140-250 
HDL 30-80 
LDL 65-130 
TGL 25-160 
VLDL 5-32 
 
The study group was compared with the above normal values. 
Statistical Analysis: 
            All the datas were entered in Microsoft excel sheets.  Statistical 
analysis was done using SPSS software SYSTAT version 7.0. 
             Mean and standard deviation were estimated in the sample for each 
study group.  Mean values were compared by using one-way ANOVA 
followed by multiple range tests by Tukey-HSD for multiple group 
comparison and students „t” test for two group comparison. 
 In the present study P <0.05 was considered as the level of 
significance.  
                            Mean (X) =  ∑ Xi 
                                                    
             n 
           
 
 
Where Xi is the individual observation and n is the sample size. 
Standard Deviation      =  
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ANOVA: 
                    Variation between observed group averages 
F Ratio=             -------------------------------------------------- 
                          Variation within each group 
 
 Students “t” test(unpaired) 
t=difference in means/standard error of difference 
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RAGAS DENTAL COLLEGE & HOSPITAL 
2/102, East Coast Road, Uthandi, Chennai – 600119 
DEPARTMENT OF ORAL MEDICINE & RADIOLOGY 
 
  CASE SHEET PROFORMA 
         
        Date: 
S.No     : 
OP.No     : 
Study group    : Group I / Group II / Group III 
Name     :                                                                                            
Age/Sex    : 
Address    : 
Phone number    : 
Occupation    : 
Monthly income   : 
Past medical /surgical/dental /history 
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HABITS 
 
PRESENT 
 
ABSENT 
 
DURATION 
 
Smoking 
     
 
Chewing 
     
 
Alcohol 
     
  : 
Leukoplakia : 
    Site : 
    Size : 
    Type : 
Oral submucous fibrosis : 
    Grade :  
Oral Squamous cell carcinoma 
     Site : 
    Size : 
    Type: 
    Clinical staging: 
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LIPID PROFILE: 
 
Parameters/ 
 
Lesion 
Total 
Cholesterol 
(TC) (mg%/) 
Lowdensity 
Lipoprotein 
(LDL) 
(mg%) 
Highdensity 
Lipoprotein 
(HDL) 
(mg%) 
 
Very Low 
Density 
Lipoprotein 
(VLDL) 
(mg%) 
      Triglyceride 
(TGL) 
(mg%) 
 
Potentially 
malignant 
disorders 
         
Oral 
Squamous 
Cell 
Carcinoma 
         
 
 Figures 
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Figure 1: Armamentarium for Clinical Examination 
 
 
 
 
 
Figure 2: Normal Mucosa 
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Figure 3: Clinical Lesion - Leukoplakia 
 
 
 
 
 
 
 
 
Figure 4: Clinical Lesion – Oral Submucous Fibrosis 
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Figure 5: Clincal Lesion-Oral Cancer 
 
 
 
 
 
 
 
Figure 6: Clinical Lesion – Oral Cancer 
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Figure 7: Materials for Sample Collection 
 
 
 
 
 
Figure 8: Materials for Biochemical Analysis 
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Figure 9: Spectrophotometer 
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The present study is a randomized case control study which was 
conducted in the Department of Oral Medicine and Radiology of Ragas 
Dental College and Hospital, Uthandi, Chennai. It was devised to estimate 
the Serum lipid profile in patients with Oral Potentially Malignant disorders, 
Oral squamous cell carcinoma and healthy controls. The study was 
conducted between March 2010-March 2011 on a total of 75 subjects with 
25 subjects in each group. The datas obtained from the study were 
statistically analysed.  The results extracted are compared with various 
variables included in the study and are presented here. 
Table 1: Sex wise distribution of subjects 
The study group consisted of a total number of 75 subjects.  Out of 
the 75 patients, 25 subjects were included in normal controls (Group I) and 
among them 17 (68%) were males and 8 (32%) were females,25 subjects 
were included in Oral Potentially malignant disorders (Group II) and among 
them 23(92%) were males and 2 (8%) were females, 25 were included in 
Oral Squamous cell carcinoma (Group III)  and among them 16 (64%) were 
males and 9 (36%) females . 
The sex wise distribution of subjects were found to be statistically 
insignificant, which means that both the experimental and control subjects 
were similar with respect to sex in distribution with p value 0.157. 
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Table 2: Age wise distribution of subjects 
The age of the subjects included in the study ranges between 20-70 
years. So the subjects were divided into five age groups which are as 
follows: 20-30 years, 31-40 years, 41-50 years, 51-60 years and 61-70 years. 
Among the 25 in group I, 09(36%) were between 20-30 years, 07(28%) 
were between 31-40 , 02(8%) were between 41-50 years  and 05(20%) were 
between 51-60 years and 02(8%) were between 61-70 years. Among the 25 
in  group II, 05(20%) were between 20-30 years, 11(44%) were between 31-
40 yrs , 8(32%) were between 41-50 years , 1(4%) were between 51-60 
years and no subjects were in the age group of 61-70 .Among the 25 in 
group III,  no subjects were in the age group of 20-30 years and  31-40 
years, 4(16%) were between 41-50 years , 10(40%) were between 51-60 
years 11(44%) were between 61-70 years.  
The age wise distribution of subjects were found to be statistically  
highly significant, which means that there exists correlation among the 3 
groups with respect to  age in distribution  with p value≤ 0.001 
Table 3: Age and Sex wise distribution of subjects in  Group-I 
Table three shows the distribution of subjects based on age and sex 
in the Group I. The age range was from 23 to 63 years with the mean age of 
39.08 years. There is a clear male predilection of 17(68%) compared to the 
females who accounted for 8 (32%) in the total of 25.  
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Table  4: Age and Sex wise distribution of subjects in  Group-II: 
Table four shows the distribution of subjects based on age and sex in 
Group-II. The age range was from 22 to 58 years with the mean age of 37.4 
years. There is a clear male predilection of 23(92%) compared to the 
females who accounted for 2(8%) in the total of 25.  
Table  5: Age and Sex wise distribution of subjects in  Group-III: 
Table five shows the distribution of subjects based on age and sex in 
Group III. The age range was from 46 to 70 years with the mean age of 
59.08 years. There is a clear male predilection of 16(64%) compared to the 
females who accounted for 9(36%) in the total of 25.  
Table 6: Show Distribution of the subjects based on the habits: 
The distributions of habits were grouped as follows, smoking, 
chewing, chewing and smoking, smoking and alcohol, chewing and alcohol, 
and chewing, smoking and alcohol.  
In group I out of the 25 (100%), subjects, 14(56%) had the no 
habits,7(28%) of only smoking, 4(16%) had the habit of only chewing, none 
had the habit of smoking,  smoking and  chewing  and alcohol consumption 
and all three habits together 
In group II among the 25 (100%), subjects, 8(32%) had the habit of 
only smoking, 14(56%) had the habit of only chewing, 3(12%) had the 
combined habits of smoking and alcohol consumption, while  none had the 
habit of smoking and chewing  ,chewing and alcohol and  all three habits 
together.  
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In group III among the 25 (100%), subjects, 14(56%) had the habit 
of only chewing, 7(28%) had the habit of  smoking  and chewing while none 
had the habit of only smoking, smoking and alcohol consumption and 
4(16%) had all three habits together.  
The distribution of subjects based on habits were found to be 
statistically significant,  with the habit of chewing , smoking, alcoholism 
alone or in combination of habits with the p value ≤ 0.000. 
Table 7: Show Distribution of the subjects according to the lesion in 
Group II: 
The subjects in Group II were divided into two classes based on the 
type of Potentially malignant disorder present as follows, Leukoplakia and 
Oral submucous fibrosis. Among the 25 (100%), subjects in Group II, 
14(56%) had Oral submucous fibrosis and 11(44%) had Leukoplakia. The 
group is constant and hence the p-value is not attained. 
Table 8: Show Distribution of the subjects according to the grades of 
OSMF in Group II: 
In Group II 14(56%) subjects out of the total of 25(100%) had 
OSMF with 4(28.6%) in Grade I, 6(42.8%) in Grade III, 4(26.6 %) in Grade 
IV and none in Grade II. The p-value is not attained as the group is constant. 
The group is constant and hence the p-value is not attained. 
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Table 9: Show Distribution of the subjects according to the site of 
Leukoplakia in Group II: 
In Group II among the total of 25 (100%) subjects, 11(44%) had 
leukoplakia in which 5(45.5%) were present in the retro-commissure area, 5 
(45.5%) in the buccal mucosa and 1(9%) in the floor of the mouth.  The 
group is constant and hence the p-value is not attained 
Table 10: Show Distribution of the subjects according to the site of 
carcinoma in Group III:  
In Group III oral carcinoma was seen in 5 different sites: tongue, 
buccal mucosa, alveolar mucosa, floor of the mouth, palate  
            In Group III among the 25 subjects, 3(12%) had carcinoma in the 
tongue, 12(48%) had in the buccal mucosa, 5(20%) had in the alveolar 
mucosa, 1(4%) had carcinoma in the floor of the mouth and 4(16%) in the 
palate. The group is constant and hence the p-value is not attained.      
Table 11: Show Distribution of the subjects according to the stages of 
OSCC in Group III: 
               In Group III, among the total of 25(100%) had OSCC with 
5(20%) in Stage I, 4(16%) in Stage II, 8(32%) in Stage III and 8(32%) in 
Stage IV. The group is constant and hence the p-value is not attained. 
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TABLE 12: LIPID PROFILE IN GROUP I, II, III 
TOTAL CHOLESTEROL IN THREE GROUPS 
          The total cholesterol (TC) levels is highest in controls (Group-I)which 
is 172.56 with a standard deviation of 29.2 followed by subjects with oral 
potentially malignant disorder (Group-II) which is 159.84±15.5 and the 
lowest value is seen with Oral Squamous Cell carcinoma (Group-III) which 
is157.56±12.3.The p value in relation to the variable TC with reference to 
Group-I,Group-II,Group-III is  <0.01  and  it is significant. 
LDL CHOLESTEROL IN THREE GROUPS          
                LDL levels is highest in controls (Group-I) which is 102.60 with a 
standard deviation of 24.4 followed by subjects with Oral Squamous Cell 
carcinoma (Group-III) which is 92.44±14.6 and the lowest value is seen 
with oral potentially malignant disease (Group-II) which is 91.16±17.0.The 
p value in relation to the variable LDL with reference to Group-I,Group-II, 
Group-III is 0.07  and  it is  insignificant. 
HDL CHOLESTEROL  IN THREE GROUPS       
              HDL levels is highest in controls  (Group-I)which is 42.76 with a 
standard deviation of 3.1 followed by subjects with oral potentially 
malignant disease (Group-II) which is 40.72±3.2 and the lowest value is 
seen with Oral Squamous Cell carcinoma (Group-III) which is 
38.92±2.5.The p value in relation to the variable HDL  with reference to 
Group-I,Group-II,Group-III is <0.001  and  it is significant. 
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VLDL CHOLESTEROL IN THREE GROUPS       
              VLDL levels is highest in controls (Group-I) which is 33.32 with a 
standard deviation of 9.4 followed by subjects with oral potentially 
malignant disease (Group-II) which is 29.96±10.7 and the lowest value is 
seen with Oral Squamous Cell carcinoma (Group-III) which is 26±9.The     
p value in relation to the variable VLDL with reference to Group-I, Group-
II,Group-III is <0.01  and  it is significant. 
TGL CHOLESTEROL IN THREE GROUPS       
              TGL levels is highest in controls (Group-I) which is 151.68with a 
standard deviation of 20.5 followed by subjects with oral potentially 
malignant disease (Group-II) which is 141.04±53.4 and the lowest value is 
seen with Oral Squamous Cell carcinoma (Group-III) which is 131.16±44.7. 
The p value in relation to the variable TGL with reference to Group-I, 
Group-II, Group-III is 0.22 and it is insignificant. 
Table 13: CORRELATION OF TOTAL CHOLESTEROL   
BETWEEN GROUP I, II &GROUPIII. 
The mean difference between Group-I and Group-II is 12.60, with   
p value < 0.01 which is significant.  The mean difference between Group-I 
and Group-III is 14.88, with p value <0.01 which is significant.   
The mean difference between Group-II and Group-I is -12.60, with  
p value <0.01 which is significant.  The mean difference between Group-II 
and Group-III is 2.28, with p value 0.91 which is insignificant.   
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The mean difference between Group-III and Group-I is-14.88, with   
p value <0.01 which is significant.  The mean difference between Group-III 
and Group-II is-2.28, with p value 0.91 which is insignificant.   
Table 14: CORRELATION OF LDL   BETWEEN  GROUP I, II & 
GROUP III: 
The mean difference between Group-I and Group-II is 11.44, with   
p value 0.09 which is insignificant.  The mean difference between Group-I 
and Group-III is 10.16, with p value 0.15 which is insignificant.   
The mean difference between Group-II and Group-I is -11.44, with  
p value 0. 09 which is  insignificant.  The mean difference between Group-II 
and Group-III is -1.28, with p value 0.97 which is insignificant.   
The mean difference between Group-III and Group-I is-10.16, with   
p value 0.15 which is insignificant.  The mean difference between Group-III 
and Group-II is 1.28, with p value 0.97 which is insignificant 
Table 15: CORRELATION OF HDL BETWEEN  GROUP I, II 
&GROUPIII: 
The mean difference between Group-I and Group-II is 1.04, with     
p value <0.05 which is significant.  The mean difference between Group-I 
and Group-III is 2.84, with p value <0.001 which is highly significant.   
The mean difference between Group-II and Group-I is -1.04, with    
p value <0.05 which is significant.  The mean difference between Group-II 
and Group-III is 1.80, with p value 0.09 which is insignificant.   
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The mean difference between Group-III and Group-I is-2.84, with    
p value <0.001 which is highly significant.  The mean difference between 
Group-III and Group-II is-1.04, with p value 0.09 which is insignificant.  
 
Table 16: CORRELATION OF VLDL BETWEEN GROUP I, II & 
GROUP III: 
The mean difference between Group-I and Group-II is 5.36, with     
p value 0.13 which is insignificant.  The mean difference between Group-I 
and Group-III is 7.32, with p value <0.05 which is significant.   
The mean difference between Group-II and Group-I is -5.36, with    
p value 0.13  which is insignificant.  The mean difference between Group-II 
and Group-III is 1.96, with p value 0.75 which is insignificant.   
The mean difference between Group-III and Group-I is-7.32, with    
p value <0.05 which is significant.  The mean difference between Group-III 
and Group-II is-1.96, with p value 0.75 which is insignificant 
Table 17: CORRELATION OF TGL  BETWEEN  GROUP I, II & 
GROUP III: 
The mean difference between Group-I and Group-II is 10.64, with   
p value 0.64 which is insignificant. The mean difference between Group-I 
and Group-III is 20.52, with p value 0.19 which is insignificant.   
The mean difference between Group-II and Group-I is -10.64, with  
p value 0.64 which is insignificant.  The mean difference between Group-II 
and Group-III is 9.88, with p value 0.68 which is insignificant.   
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The mean difference between  Group-III and Group-I is-20.52, with 
p value 0.19 which is insignificant.  The mean difference between Group-III 
and Group-II is -9.88, with p value 0.68 which is insignificant 
TABLE 18: CORRELATION OF LIPID PROFILE WITH AGE IN 
GROUP I (CONTROL) 
         TC is 171.24± 32.71 in the males and 175.00±22.04 in the females. TC 
is more in females when compared to males, however the differences are not 
statistically significant with p value 0.07.LDL is 102.82±27.27 in males and 
102.13± 18.77 in females.LDL is almost equal in both the groups and the 
difference is statistically insignificant with p value 0.09.HDL is more in 
females with value of 42.25± 4.2 and less in males with value of 
41.53±2.70. The difference is not statistically significant with p value of 
0.06.VLDL in males is 30.82±7.00 and in females is 38.63± 12.06. VLDL is 
more in females with difference which is statistically significant with           
p value of <0.05. TGL in males is 154.47±18.89 and in females is 
145.75±24.03.TGL is more in males when compared to females. However 
the differences are not statistically significant with p value of 0.38 
TABLE 19: CORRELATION OF LIPID PROFILE WITH AGE IN 
GROUP II (OPC) 
         TC is 161.13± 15.55 in the males and 145.00±1.41  in the females. TC 
is more in males when compared to females, however the differences are not 
statistically significant with p value 0.16. LDL is 92.04±17.52  in males and 
81± 4.24 in females.LDL is more in males when compared to females but  
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the difference is statistically insignificant with p value 0.06. HDL is more in 
males with value of 40.83± 0.3 and less in females with value of 39.5±0.71. 
The difference is not statistically significant with p value of 0.16. VLDL in 
males is 28.26±11.17 and in females is 24.50± 2.12. VLDL is more in males 
with difference which is not statistically significant with p value of 0.20. 
TGL in males is 142.52±55.11 and in females is 124±9.90.TGL is more in 
males when compared to females. However the differences are not 
statistically significant with p value of 0.19 
TABLE 20:  CORRELATION OF LIPID PROFILE WITH AGE IN 
GROUP III (OSCC) 
         TC is 155.19± 11.76 in the males and 161.78±12.99 in the females. TC 
is more in females when compared to males, however the differences are not 
statistically significant with p value 0.20. LDL is 87.88±12.76 in males and 
100.56± 14.89 in females.LDL is more in females when compared to males 
but  the difference is statistically insignificant with p value 0.35. HDL is 
almost equal in both groups , in males with value of 39.94± 2.93 and  in 
females with value of 39.8±2.03. The difference is not statistically 
significant with p value of 0.95. VLDL in males is 28.06±9.66 and in 
females is 22.33± 6.96. VLDL is more in males with difference which is not 
statistically significant with p value of 0.16. TGI in males is 140.50±48.59 
and in females is 114.56±33.03.TGI is more in males when compared to 
females. However the differences are not statistically significant with              
p value of 0.12. 
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TABLE 21 CORRELATION OF DURATION OF HABITS AND 
LIPID PROFILE IN OPC 
       Group II (PMD) had 25 patients. They were divided on the basis of 
duration of habits in to two categories namely Category A –Subjects with 
the habit for less than 15 years and Category B –Subjects with the habit for 
more than 15 years. 11 subjects had habit for less than 15 years and 14 
subjects had habits more than 15 years. TC is 155.91±11.37 in the habit less 
than 15 years group and 162.93± 17.96 in habit more than 15 years 
group.TC is more in Category B. The difference is not statistically 
significant with p value of 0.27. LDL is 86.00±17.69 in the habit less than 
15 years group and 95.21± 16.03 in habit more than 15 years group. LDL is 
more in Category B. The difference is not statistically significant with         
p value of 0.18. HDL is 39.93±2.58 in the habit less than 15 years group and 
41.73± 3.77 in habit more than 15 years group .HDL is more in Category B. 
The difference is not statistically significant with p value of 0.16. VLDL is 
27.78±9.56 in the habit less than 15 years group and 28.18± 12.59 in habit 
more than 15 years group. VLDL is more in Category B.  The difference is 
not statistically significant with p value of 0.9. TGL is 139.50±47.57 in the 
habit less than 15 years group and 143± 61.67 in habit more than 15 years 
group. TGL is more in Category B. The difference is not statistically 
significant with p value of 0.8 
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TABLE 22: CORRELATION OF TYPES OF LEUKOPLAKIA AND 
LIPID PROFILE:   
The subjects in Group II were divided into two classes based on the 
type of Potentially malignant disorder present as follows, Leukoplakia and 
Oral submucous fibrosis.  Among 11 subjects who had Leukoplakia, 7 
subjects had homogenous type and 4 had speckled type.TC is 162.14±13.05 
in homogenous type and 151± 9.83 in speckled type .TC  is more in 
homogenous type. The difference is not statistically significant with p value 
of 0.17. LDL is 96.67±11.88 in homogenous type and 70.75± 14.24 in 
speckled type  LDL is more in homogenous type .The difference is not 
statistically significant with p value of 0.15. HDL is 43.14±3.13 in 
homogenous type and 41.25± 4.64 in speckled type. HDL is more in 
homogenous type. The difference is statistically significant with p value of 
<0.05. VLDL is 24.28±5.82 in homogenous type and 37± 18.34  in speckled 
type. VLDL is more in speckled type. The difference is not statistically 
significant with p value of 0.1. TGL is 124.29 ±8.85 in homogenous type 
and 185±46.46 in speckled type. TGL is more in speckled type. The 
difference is not statistically significant with p value of 0.12. 
TABLE 23: CORRELATION OF GRADES OF OSMF AND LIPID 
PROFILE:  
               The subjects in Group II were divided into two classes based on 
the type of potentially malignant disorder present as follows, Leukoplakia 
and Oral submucous fibrosis.Among 14 subjects who had OSMF, 4 subjects 
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were in Grade I , 6 subjects were in Grade III, 4 subjects were in Grade IV 
and none in Grade II.TC is 165.65±18.26 in Grade I, 148.67±4.08 in Grade 
III and 175.75±19.67 in Grade IV.TC is highest in  Grade IV followed by 
Grade I and Grade III. The difference is not statistically significant with         
p value of 0.36. LDL is 101.75±18.96 in Grade I, 84±4.24 in Grade III and 
102.00±20.51 in Grade IV.LDL is highest in Grade IV followed by Grade I 
and Grade III. The difference is not statistically significant with p value of 
0.12. HDL is 39.25±1.25 in Grade I, 38.67±1.36 in Grade III and 
42.00±3.74 in Grade IV. HDL is highest in Grade IV followed by Grade I 
and Grade III. The difference is not statistically significant with p value of 
0.10. VLDL is 24.50±1.00 in Grade I, 26±3.57 in Grade III and 31.75±17.74 
in Grade IV. VLDL is highest in Grade IV followed by Grade III and Grade 
I. The difference is not statistically significant with p value of 0.5. TGL is 
123.50±7.32 in Grade I, 131.17±16.25 in Grade III and 158.75 ±9.61 in 
Grade IV. TGL is highest in Grade IV followed by Grade III and Grade I. 
The difference is not statistically significant with p value of 0.56. 
TABLE 24:  CORRELATION OF DURATION OF HABITS AND 
LIPID PROFILE IN OSCC: 
Group III (OSCC) had 25 patients. They were divided  on the basis 
of duration of habits into two categories  namely  those had   the habit for 
less than 15 years and those had the  habit for more than 15 years.1 subject 
had habit for less than 15 years and 24 subjects had habits more than 15 
years. TC is 171 in the habit less than 15 years group and  157± 12.31  in 
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habit more than 15 years group which is more  than the second category. 
The difference is not statistically significant with p value of 0.27. LDL is 
115 in the habit less than 15 years group and 91.5± 14.16 in habit more than 
15 years group which is more than the second category. The difference is 
not statistically significant with p value of 0.11. HDL is 40 in the habit less 
than 15 years group and 38.88± 2.66 in habit more than 15 years group 
which is more than the second category. The difference is not statistically 
significant with p value of 0.68. VLDL is 16 in the habit less than 15 years 
group and 26.14± 9.02 in habit more than 15 years group which is less than 
the second category. The difference is not statistically significant with             
p value of 0.27. TGL is 81 in the habit less than 15 years group and 133.25± 
43.43 in habit more than 15 years group which is less than the second 
category. The difference is not statistically significant with p value of 0.26 
TABLE 25: CORRELATION OF STAGES OF OSCC AND LIPID 
PROFILE: 
              Among  the 25 subjects in Group III (OSCC)  5 subjects were in 
Stage I , 4 subjects were in Stage II, 8 subjects were in Stage  III and 8 
subjects  in Grade IV .TC is 165.6±7.40 in Stage I , 172.7±2.63 in Stage  II, 
and 149.7±13.04 in Stage III and 152.7±6.79 in Stage IV. TC is highest in 
Stage II followed by Stage I, Stage IV and Stage III. The difference is 
statistically significant with p value of 0.00. LDL is 105.80±13.33 in Stage 
I, 109.50±4.04  in Stage  II, and 83.25±12.78 in Stage III and 84.75±2.25 in 
Stage IV. LDL is highest in Stage II followed by Stage I, Stage IV and 
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Stage III. The difference is not statistically significant with p value of 0.35. 
HDL is 39.20±0.83 in Stage I , 40.75±1.70  in Stage  II, and 37.88±2.85 in 
Stage III and 38.88±3.18 in Stage IV. HDL is highest in Stage II followed 
by Stage I, Stage IV and Stage III. The difference is statistically significant 
with p value of 0.00. VLDL is 19.60±4.92 in Stage I , 22.50±2.64 in Stage  
II, and 28.62±12.81 in Stage III and 29.12±6.79 in Stage IV. VLDL is 
highest in Stage IV followed by Stage III, Stage II and Stage I. The 
difference is  not statistically significant with p value of 0.19. TGL is 
98.60±25.22 in Stage I , 120.25±16.64 in Stage  II, and 143.75±64.22 in 
Stage III and 144.38±32.37 in Stage IV. TGL is highest in Stage IV 
followed by Stage III, Stage II and Stage I. The difference is not statistically 
significant with p value of 0.24. 
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GRAPH  – 1: DISTRIBUTION OF SUBJECTS BY SEX 
 
 
GRAPH – 2: DISTRIBUTION OF SUBJECTS BY AGE 
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GRAPH – 3: DISTRIBUTION OF SUBJECTS BASED ON HABITS 
 
 
 
GRAPH – 4 DISTRIBUTION OF SUBJECTS ACCORDING TO 
LESION  IN GROUP II 
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GRAPH – 5 DISTRIBUTION OF SUBJECTS ACCORDING TO THE 
GRADE OF ORAL SUBMUCOUS FIBROSIS 
 
 
 
 
GRAPH – 6 DISTRIBUTION OF SUBJECTS ACCORDING TO 
THE SITE OF LEUKOPLAKIA 
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GRAPH  – 7 DISTRIBUTION OF SUBJECTS ACCORDING TO THE 
SITE OF CARCINOMA IN GROUP III 
 
 
GRAPH – 8 DISTRIBUTION OF SUBJECTS ACCORDING TO THE 
CLINICAL STAGING  OF  GROUP III 
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TABLE 9 LIPID PROFILE IN GROUP I,II,III 
 
 
 
GRAPH  10  CORRELATION OF LIPID PROFILE WITH AGE IN 
GROUP I(CONTROL) 
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GRAPH  11  CORRELATION OF LIPID PROFILE WITH AGE IN 
GROUP II(PMD) 
 
GRAPH  12  CORRELATION OF LIPID PROFILE WITH AGE IN 
GROUP III(OSCC) 
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GRAPH  13 CORRELATION OF DURATION OF HABITS AND LIPID 
PROFILE IN PMD 
 
 
GRAPH  14  CORRELATION OF TYPES OF LEUKOPLAKIA AND 
LIPID PROFILE 
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GRAPH  15 CORRELATION OF GRADES OF OSMF AND LIPID 
PROFILE 
 
 
GRAPH 16 CORRELATION OF DURATION OF HABITS AND LIPID 
PROFILE IN OSCC 
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GRAPH  17  CORRELATION OF STAGES OF OSCC AND LIPID 
PROFILE 
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Table 1: Distribution of Subjects by Sex 
 
p value  0.157 (not significant) 
 
Table 2: Distribution of Subjects by Age 
 
AGE 
(Years) 
GROUP I 
(CONTROL) 
GROUP II 
(OPC) 
GROUP III 
(OSCC) 
 
TOTAL 
 
21-30 
 
9 
 
36% 
 
5 
 
20% 
 
0 
 
0% 
 
14 
 
18.67% 
 
31-40 
 
7 
 
28% 
 
11 
 
44% 
 
0 
 
0% 
 
18 
 
24.0% 
 
41-50 
 
2 
 
8% 
 
8 
 
32% 
 
4 
 
16% 
 
14 
 
18.67 % 
 
51-60 
 
5 
 
20% 
 
1 
 
4% 
 
10 
 
40% 
 
16 
 
21.33% 
 
61-70 
 
2 
 
8% 
 
0 
 
0% 
 
11 
 
44% 
 
13 
 
17.33% 
 
TOTAL 
 
25 
 
100% 
 
25 
 
100% 
 
25 
 
100% 
 
75 
 
100% 
 
p value ≤  0.001 (  Highly significant) 
 
 
SEX 
 
GROUP I 
(controls) 
GROUP II 
(oral 
potentially 
malignant 
disorders) 
GROUP III 
(oral 
squamous 
cell 
carcinoma) 
 
 
TOTAL 
 
MALE 
 
17 
 
68% 
 
23 
 
92% 
 
16 
 
64% 
 
56 
 
74.7% 
 
FEMALE 
 
8 
 
32% 
 
2 
 
8% 
 
9 
 
36% 
 
19 
 
25.3% 
 
TOTAL 
 
25 
 
100% 
 
25 
 
100% 
 
25 
 
100% 
 
75 
 
100% 
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Table 3: Age and Sex Wise Distribution of Subjects  in Group-I 
(Control) 
 
SNO AGE SEX 
1 35 F 
2 23 F 
3 30 M 
4 35 F 
5 52 M 
6 25 M 
7 27 M 
8 29 M 
9 63 F 
10 57 M 
11 37 M 
12 63 F 
13 58 F 
14 42 M 
15 33 M 
16 44 M 
17 32 M 
18 37 M 
19 27 F 
20 30 M 
21 23 F 
22 40 M 
23 58 M 
24 52 M 
25 25 M 
    
 
 
Age range : 23-63 Years                       Mean age –39.08 Years  
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Table 4: Age and Sex Wise Distribution of Subjects in Group-II 
 
SNO AGE SEX 
1 47 M 
2 25 M 
3 38 M 
4 35 M 
5 35 F 
6 25 M 
7 27 M 
8 43 M 
9 35 M 
10 44 M 
11 35 M 
12 22 M 
13 37 F 
14 33 M 
15 42 M 
16 22 M 
17 42 M 
18 48 M 
19 48 M 
20 31 M 
21 48 M 
22 39 M 
23 38 M 
24 58 M 
25 38 M 
 
 Age range: 22-58 Years                                   Mean age –37.4 Years       
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Table 5: Age and Sex Wise Distribution of Subjects in Group-III 
 
SNO AGE SEX 
1 51 M 
2 49 M 
3 58 M 
4 55 M 
5 62 M 
6 60 M 
7 70 F 
8 63 M 
9 67 F 
10 64 M 
11 58 M 
12 53 M 
13 46 F 
14 50 F 
15 63 F 
16 59 M 
17 67 F 
18 50 M 
19 66 F 
20 70 F 
21 61 M 
22 59 F 
23 65 M 
24 58 M 
25 53 M 
                                                                                   
Age range : 46-70 Years                                   Mean age –59.08Years  
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Table 6: Distribution of Subjects Based on Habits in Group I, Group II, 
Group III 
 
 
 
 
HABIT/ 
GROUP 
 
 
No  
Habits 
 
Only 
Smoking 
 
 
Only 
Chewing 
 
Smoking+ 
Chewing 
 
 
Smoking 
+ 
Alcohol 
 
Smoking + 
Chewing 
+ 
Alcohol 
 
 
Total 
 
Group I 14 56% 7 28% 4 16% 0 0% 0 0% 0 0% 25 100% 
Group 
II 
0 0% 8 32% 14 56% 0 0% 3 12% 0 0% 25 100% 
Group 
III 
0 0% 0 0% 14 56% 7 28% 0 0% 4 16% 25 100% 
Total 14 18.7% 15 20% 32 42.7% 7 9.3% 3 4% 4 5.3% 75 100% 
 
 
p value ≤0.000 (significant) 
 
 
Table 7:  Distribution of Subjects According to Lesion 
 
 
 
 
 
GROUP – II 
 
TOTAL 
 
 
LESION 
 
OSMF 
 
14 
 
56% 
 
14 
 
56% 
 
LEUKOPLAKIA 
 
11 
 
44% 
 
11 
 
44% 
 
TOTAL 
 
25 
 
100% 
 
25 
 
100% 
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Table 8:  Distributions of Subjects According to the Grade of Oral 
Submucous Fibrosis 
 
 GROUP – II TOTAL 
 
 
 
 
OSMF 
GRADE 
 
GRADE I 
 
4 
 
28.6% 
 
2 
 
28.6% 
 
GRADE II 
 
0 
 
0% 
 
0 
 
0% 
 
GRADE III 
 
6 
 
42.8% 
 
5 
 
42.8% 
 
GRADE IV 
 
 
4 
 
26.6% 
 
4 
 
28.6% 
 
TOTAL 
 
14 
 
100% 
 
14 
 
100% 
 
 
 
Table 9:  Distribution of Subjects According to the Site of Leukoplakia 
 
 
  
GROUP – II 
 
TOTAL 
 
 
 
 
LEUKOPLAKIA 
SITE 
RETRO 
COMMISSURE 
AREA 
 
5 
 
45.5% 
 
5 
 
45.5% 
BUCCAL 
MUCOSA 
 
5 
 
45.5% 
 
5 
 
45.5% 
FLOOR OF 
THE MOUTH 
 
1 
 
9 % 
 
1 
 
9% 
 
TOTAL 
 
11 
 
100% 
 
11 
 
100% 
 
 
 
 
 
 
 
 
Tables & Graphs 
 
 
 
100 
 
 
Table 10:  Distribution of Subjects According to the Site of Carcinoma 
 
 
 
SITE 
 
GROUP III 
 
 
 
 
 
 
CARCINOMA 
SITE 
TONGUE 3 12% 
BUCCAL 
MUCOSA 
12 48% 
ALVEOLAR 
MUCOSA 
5 20% 
FLOOR OF THE 
MOUTH 
1 4% 
 
PALATE 
4 16% 
TOTAL 25 100% 
 
 
 
 
Table 11: Distribution of Subjects According to the Clinical Staging of 
Oral Squamous Cell Carcinoma 
 
 GROUP – III 
 
 
 
 
CLINICAL STAGE 
 
STAGE I 
 
5 
 
20% 
 
STAGE II 
 
4 
 
16% 
 
STAGE III 
 
8 
 
32% 
 
STAGE IV 
 
 
8 
 
32% 
 
TOTAL 
 
25 
 
100% 
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Table 12: Lipid Profile in Group I, II, III 
 
GROUPS NUMBER 
OF 
SUBJECTS 
TC 
Mg% 
LDL 
Mg% 
HDL 
Mg% 
VLDL 
Mg% 
TGL 
Mg% 
I 25 172.56±
29.2 
102.60±
24.2 
42.76± 
3.1 
33.32± 
9.4 
151.68±20.5 
 
II 25 159.84±
15.5 
91.16± 
17.0 
40.72± 
3.2 
27.96± 
10.7 
141.04±53.4 
 
III 25 157.44±
12.3 
92.44± 
14.6 
38.92± 
2.5 
26.00± 
26.9 
131.16±44.7 
 
ANOVA 
 
F 
P 
3.84 
0.01 
 
2.26 
0.07 
5.70 
0.001 
3.75 
0.01 
1.50 
0.22 
 
   p<0.01-Significant                                 p<0.001-Highly significant                             
   p>0.05- Not significant     
 
Table 13:  Correlation of Total Cholesterol between Group I, II 
&Group III 
GROUP(A) 
 
GROUP(B) Mean difference 
(A) - (B) 
 
Test of 
significance(p) 
GROUP-I 
 
GROUP-II 
GROUP-III 
12.60 
14.88 
  0.01  
0.01  
GROUP-II 
 
GROUP-I 
GROUP-III 
-12.60 
2.28 
0.01  
0.91  
GROUP-III 
 
GROUP-I 
GROUP-II 
 
-14.88 
-2.28 
0.01  
0.91  
 
 
   p<0.01-Significant                    p>0.05- Not significant 
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Table 14 : Correlation of LDL between the Groups I,II,III 
GROUP(A)            GROUP(B) Mean 
difference 
(A) - (B) 
 
Test of 
significance(p) 
GROUP-I               
 
GROUP-II 
GROUP-III 
11.44 
10.16 
0.09  
0.15  
GROUP-II             
 
GROUP-I 
GROUP-III 
-11.44 
-1.28 
0.09  
0.97  
GROUP-III            
 
GROUP-I 
GROUP-II 
-10.16 
1.28 
0.15  
0.97  
  p>0.05- Not significant 
Table 15 : Correlation of HDL  Between the  Groups I,II,III 
GROUP(A)            GROUP(B)          Mean 
difference 
(A) - (B) 
 
Test of 
significance(p) 
GROUP-I               
 
GROUP-II 
GROUP-III          
1.04 
2.84 
0.05  
0.001  
GROUP-II             
 
GROUP-I 
GROUP-III          
-1.04 
1.80 
0.05 
0.09  
GROUP-III            GROUP-I 
GROUP-II          
-2.84 
-1.04 
0.001  
0.09  
 P<0.05-significant     p<0.001- highly  significant 
 p>0.05- Not significant 
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Table 16:  Correlation of VLDL between the Groups I, II, III 
GROUP(A)            GROUP(B) Mean 
difference 
(A) - (B) 
 
Test of 
significance(p) 
GROUP-I               
 
GROUP-II 
GROUP-III 
5.36 
7.32 
0.13  
<0.05  
GROUP-II             
 
GROUP-I 
GROUP-III 
-5.36 
1.96 
0.13  
0.75  
GROUP-III            
 
GROUP-I 
GROUP-II 
-7.32 
-1.96 
<0.05  
0.75  
 P<0.05-significant                                     p>0.05- Not significant                                                                          
 
Table 17: Correlation of  TGL between the  Groups I,II,III 
 
GROUP(A)            GROUP(B) Mean difference 
(A) - (B) 
 
Test of 
significance (p) 
GROUP-I               
 
GROUP-II 
GROUP-III 
10.64 
20.52 
0.64  
0.19 
GROUP-II             
 
GROUP-I 
GROUP-III 
-10.64 
9.88 
0.64  
0.68  
GROUP-III            GROUP-I 
GROUP-II 
-20.52 
-9.88 
0.19  
0.68  
p>0.05- Not significant 
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Table 18:  Correlation of Lipid Profile with Age in Group I (Control) 
 
GROUPS GENDER NUMBER TC 
mg% 
LDL 
mg% 
HDL 
mg
% 
VLDL 
mg% 
TGL 
mg% 
 
CONTROLS 
MALE 17 171.24
± 
32.71 
102.82
± 
27.27 
41.53
± 
2.70 
30.82± 
7.00 
154.47 
± 
18.89 
FEMALE 8 175.00
± 
22.04 
102.13
± 
18.77 
42.25
± 
4.20 
38.63± 
12.06 
145.75 
± 
24.03 
MvS F T 
P 
2.97 
0.07 
0.655 
0.09 
0.52 
0.06 
0.561 
<0.05 
0.998 
0.38 
 
Table 19:  Correlation of Lipid Profile with Age in Group II (PMD) 
GROUPS GENDER NUMBER TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
 
PMD 
MALE 23 161.13± 
15.55 
92.04± 
17.52 
40.83± 
0.3 
28.26± 
11.17 
142.52± 
55.11 
FEMALE 2 145.00± 
1.41 
81.00± 
4.24 
39.50± 
0.71 
24.50± 
2.12 
124.00± 
9.90 
MvS F T 
P 
1.43 
0.16 
0.83 
0.06 
0.55 
0.16 
0.46 
0.20 
0.47 
0.19 
 
Table 20:   Correlation of Lipid Profile with Age in Group III(OSCC) 
 
GROUPS GENDER NUMBER TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
 
OSCC 
MALE 16 155.19± 
11.76 
87.88± 
12.76 
38.94± 
2.93 
28.06± 
9.66 
140.50± 
48.59 
FEMALE 9 161.78± 
12.99 
100.56± 
14.89 
38.89± 
2.03 
22.33± 
6.96 
114.56± 
33.03 
MvS F T 
P 
1.29 
0.20 
2.24 
0.35 
0.04 
0.95 
1.55 
0.16 
1.43 
0.12 
 
P<0.05-  significant                           p>0.05- Not significant  
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Table 21: Correlation of Duration of Habits and Lipid Profile in PMD 
 
 
DURATION Number 
of cases 
TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
LESS THAN 
15 YEARS 
 
14 
155.91± 
11.37 
86.00± 
17.69 
39.93± 
2.58 
27.78± 
9.56 
139.50± 
47.57 
MORE 
THAN  15  
YEARS 
 
11 
162.93± 
17.96 
95.21± 
16.03 
41.73± 
3.77 
28.18± 
12.59 
143.00± 
61.67 
T 
P 
 1.12 
0.27 
1.36 
0.18 
1.42 
0.16 
0.90 
0.9 
1.60 
0.8 
p>0.05- Not significant 
 
Table 22:  Correlation of Clinical Types of Leukoplakia and Lipid 
Profile 
 
TYPES OF 
LEUKOPLAKIA 
 
Number 
of cases 
TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
HOMOGENOUS 
 
7 162.14
± 
13.05 
96.67
± 
11.88 
43.14
± 
3.13 
24.28 
± 
5.82 
124.29
± 
8.85 
SPECKLED 
 
4 151.00
± 
9.83 
70.75
± 
14.24 
41.25
± 
4.64 
37 
± 
18.34 
185.00
± 
46.46 
T 
P 
 1.47 
0.17 
3.25 
0.15 
0.907 
<0.05 
1.74 
0.1 
0.28 
0.12 
 
 
P< 0.05-Significant 
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Table 23:  Correlation of Grades of OSMF and Lipid Profile 
 
GRADES 
OF 
OSMF 
Number 
of cases 
TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
GRADE1 
 
4 165.65± 
18.26 
101.75± 
18.96 
39.25± 
1.25 
24.50± 
1.00 
123.50± 
7.32 
GRADE 2 
 
0 
     
GRADE3 
 
6 148.67± 
4.08 
84.00± 
4.24 
38.67± 
1.36 
26.00± 
3.57 
131.17± 
16.25 
GRADE 4 
 
4 175.75± 
19.67 
102.00± 
20.51 
42.00± 
3.74 
31.75± 
17.74 
158.75± 
9.61 
F 
P 
 4.56 
0.36 
2.47 
0.12 
2.77 
0.10 
.656 
0.5 
0.608 
0.56 
                         p>0.05- Not significant 
 
Table 24 : Correlation of Duration of Habits and Lipid Profile in OSCC 
 
DURATION Number 
of cases 
TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
LESS THAN 
15 YEARS 
 
 
1 171 115 40 16 81 
ABOVE 15  
YEARS 
 
 
24 
157± 
12.31 
91.5± 
14.16 
38.88± 
2.66 
26.41± 
9.02 
133.25± 
43.43 
T 
P 
 1.114 
0.27 
1.626 
0.11 
.417 
0.68 
1.131 
0.27 
1.152 
0.26 
 
p>0.05- Not significant 
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Table 25: Correlation of Stages of OSCC and Lipid Profile 
 
 
P=0.00-  significant                           p>0.05- Not significant 
GRADES 
OF OSCC 
Number 
of cases 
TC 
mg% 
LDL 
mg% 
HDL 
mg% 
VLDL 
mg% 
TGL 
mg% 
STAGEI 5 
 
165.6± 
7.40 
105.80± 
13.33 
39.20± 
0.83 
19.60± 
4.92 
98.60± 
25.22 
STAGE II 4 
 
172.7± 
2.63 
109.50± 
4.04 
40.75± 
1.70 
22.50± 
2.64 
120.25± 
16.64 
STAGE  III 8 
 
149.7± 
13.04 
83.25± 
12.78 
37.88± 
2.85 
28.62± 
12.81 
143.75± 
64.22 
STAGE 1V 8 
 
152.7± 
6.79 
84.75± 
2.25 
38.88± 
3.18 
29.12± 
6.79 
144.38± 
32.37 
F 
P 
 7.65 
0.00 
11.57 
0.35 
1.13 
0.00 
1.70 
0.19 
1.49 
0.24 
     Discussion 
 
 
117 
 
In India, oral cancer is prevalent in most areas where tobacco related 
practices are observed. For development of oral cancer, tobacco is the single 
greatest risk factor. When this is combined with arecanut the risk increases 
many fold. Alcohol, viruses, genetic mechanisms, candida, chronic irritation 
and diet deficiency states are also implicated in the etiology.
84 
Cancer is a class of diseases in which a group of cells display 
uncontrolled growth , invasion and sometimes metastasis. These three 
malignant properties of cancers differentiate them from benign tumors, 
which are self-limited, and do not invade or metastasize. 
11
 
           Head and neck malignancies rank among top three malignancies in 
our country for both males and females. The wide spread use of tobacco in 
various forms due to our cultural habits coupled with lack of awareness of it 
carcinogenic effects are responsible for their prevalence. Ignorance of early 
symptoms together with lack of proper diagnostic and treatment facilities at 
the gross root level lead to presentation of patients to cancer hospitals in 
advanced disease status in our country.
85
 
Oral cancer is almost always preceded by benign lesions or 
conditions for varying lengths of time.  Interestingly the benign lesions and 
conditions also share the same risk factors as the cancer, particularly the 
tobacco and the areca nut.  Many of these have the potential to become 
cancer and are termed as precancerous lesions and conditions. 
84 
 
Significant reduction in mortality can be achieved by advances in 
early diagnosis and implementation of multidisciplinary treatment 
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programmes leading to improvement of survivorship and better quality of 
life.  
Among the oral tumors 90% are oral squamous cell carcinoma 
which arise from the mucosal lining. Inspite of significant advances in 
surgery, radiotherapy and chemotherapy the 5 year survival rate has 
remained at about 52% for the past few decades. 
The development of oral cancer is a multistep process arising from 
pre-existing potentially malignant lesions. Leukoplakia is the most common 
precancer representing 85% of such lesion.
15
 
             Cholesterol is an amphipathic lipid and as such, is an essential 
structural component of all cell membranes and of the outer layer of plasma 
lipoproteins. It is present in tissues and in plasma lipoprotein either as free 
cholesterol or combined with a long-chain fatty acid, as cholesteryl ester. It 
is synthesized in many tissues from acetyl-CoA and is ultimately eliminated 
from the body in the bile as cholesterol or bile salts. Lipoprotein transports 
free cholesterol in the circulation, where it readily equilibrates cholesterol in 
other lipoproteins and in membranes. Of the lipoprotein
 
fractions, LDL most 
clearly reflects the decrease in total
 
cholesterol. The role of HDL and 
triglycerides in explaining the overall pattern of total cholesterol change is 
less clear.
 81 
         Regulation of cholesterol is mediated by lipoprotein receptors. Plasma 
triglycerides and cholesterol are packed into lipoproteins for transport. 
Cholesterol is an essential constituent of lipoprotein fractions like LDL, 
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HDL, and VLDL. Seventy five percent of the plasma cholesterol is 
transported in the form of LDL. Cells sequester cholesterol from LDL 
fraction of lipoproteins. High activity of LDL receptors attributes for 
lowering the serum cholesterol levels. The individuals having deficient or 
defective LDL receptors remove plasma LDL at much lower rate and have 
considerably elevated levels. 
In some malignancies, serum cholesterol undergoes early and 
significant changes. Low levels of cholesterol in the proliferating tissues and 
in blood compartments could be due to the rapidly dividing cells in 
malignancies. The habit of tobacco consumption is a known etiological 
factor for development of oral precancerous disease and head and neck 
cancer. Patients with oral precancerous conditions have also been reported 
to show a significant tendency to develop cancer. It is believed that tobacco 
carcinogens and excessive use of areca nut induce generation of free 
radicals and reactive oxygen species, which are responsible for high rate of 
oxidation / peroxidation of polyunsaturated fatty acids. Because of lipid 
peroxidation there is greater utilization of lipids including total cholesterol, 
lipoproteins and triglycerides for new membrane biogenesis. Cells fulfill 
these requirements either from circulation, by synthesis through metabolism 
or from degradation of major lipoprotein fractions like VLDL, LDL, and 
HDL 
5.
 
The present study was done to validate Serum lipid changes as 
biological marker for Oral Potentially malignant disorders and Oral 
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squamous cell carcinoma. In the study the levels of serum lipid in subjects 
with untreated Oral Leukoplakia , Oral submucous fibrosis and Oral 
squamous cell carcinoma were determined 
The Serum lipid levels were compared with Oral Potentially Malignant 
Disorders, Oral squamous cell carcinoma and  with the control group  Finally  the 
relation between serum lipids  with Oral Potentially Malignant Disorders and Oral 
squamous cell carcinoma were determined. 
             This is a cross sectional hospital based study conducted between March 2010 
to March 2011, and the type of study is a case control study. The study subjects were 
categorized  into three groups: Group I consisting of 25 normal controls, Group II 
consist of 25 patients who were suffering from Potentially Malignant Disorders like 
Leukoplakia and Oral submucous fibrosis; Group III, 25 patients suffering from Oral 
cancer. 
STUDY ANALYSIS: 
Age & Sex: 
            Among the 75 subjects 56(74.7%) were males and 19(25.3%) were 
females. The minimum age of the study subjects was 22 years and the 
maximum age was 70 years 
HABITS 
        In the present study, among the 75 subjects 15(20%) had the habit of 
smoking, 32(42.7%) had the habit of chewing, 7(9.3%) had the habit of 
chewing and smoking, 3(4%) had the habit of smoking and alcohol 
consumption and 4(5.3%) had all three habits together with a p-value ≤ 
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0.000 which is statistically significant. Thus a positive correlation between 
smoking, chewing, alcohol consumption and development of precancer and 
cancer has been established. 
This is in accordance with various studies. Sugár.L. et al 
16
 made a 
follow-up study with 324 patients and concluded that there was a 
relationship between smoking and the frequency of leukoplakia. Pindborg 
et al 
8 
examined 1866 individuals and found a positive correlation between 
Preleukoplakia and leukoplakia and the habit of smoking. Salonen et al
45  
reported a positive correlation between tobacco use and leukoplakia on his 
study on 920 individuals.  
             Shah N et al 
33 
reported that chewing of areca nut, quid and pan 
masala was directly related to oral submucous fibrosis and not a single case 
was found without any chewing habit in a study comprising 236 cases of 
oral submucous fibrosis which were compared with 221 control subjects 
matched for age, sex and socioeconomic conditions.  
Sankaranarayanan 
46
 found a causal association between oral 
cancer and the chewing of betel quid containing tobacco leaves or stem and 
other tobacco habits.  
Rajendran.R 
30
 reviewed the etiology and pathogenesis of Oral 
submucous fibrosis. He suggested that certain customs or habits (chewing) 
prevalent among the population groups in South East Asia might be possible 
etiological factors.  
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Shah N, Sharma PP 
33
 conducted a study to identify the role of 
chewing and smoking habit in the etiology of oral submucous fibrosis. In 
this study 236 cases of oral submucous fibrosis were compared with 221 
control subjects matched for age, sex and socioeconomic conditions. It was 
found that chewing of areca nut, quid and pan masala was directly related to 
oral submucous fibrosis and not a single case was found without any 
chewing habit.                   
 Crispian Scully et al 
50
 stated that the etiological factors of oral 
cancer include tobacco use, betel use (Bidi leaf, and often tobacco, plus 
spices,
 
slaked lime, and areca nut) and alcohol consumption. 
 Zain et al 
52
 stated about the role of tobacco smoking, chewing of 
tobacco, areca nut, and betel quid and drinking of alcohol are established 
cultural risk factors of oral pre-cancer and oral cancer worldwide.  
Saraswathi et al 
12
 stated that the habit of smoking, drinking and 
chewing tobacco products were common oral habits in India and these 
habits were positively related with development of oral lesion such as 
OSMF, leukoplakia and oral lichen planus which had potential for 
malignant transformation. 
SITE OF LEUKOPLAKIA 
In the present study, the most common site for leukoplakia was in 
the retro-commissure area with 5(45.5%) and  buccal mucosa 5 (45.5%) and 
one in the floor of the mouth.  
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         This  is  consistent with the study conducted by Reichart PA and 
Kohn H in   1996 
86
 in which they found the retrocommisure was the most 
commonly affected site upto 43.35 followed by 36.7% in buccal mucosa. 
In a 10 year follow up study conducted in Mumbai Napier SS and 
Speight PM.in 2008
 87
 80% lesions were found in retrocommisure and 
buccal mucosa and 5% found in tongue 
CLINICAL GRADING 
The present study showed all cases of OSMF in the buccal mucosa, 
with 6(42.8%) in Grade III and 4 each in Grades I and IV and none in Grade 
II.  
This is consistent with the study done by Shah et al 
33
 stated that 
OSMF predominantly affects the buccal mucosa with the p-value <0.001.  
This Grade III predominance of clinical presentation can be 
attributable to the fact that the presence of blanching and  burning sensation, 
dryness of   mouth, vesicles or ulcers in the mouth with  restriction of mouth 
opening and palpable bands all over the mouth with out tongue involvement 
which causes major morbidity to the patient making them to seek dental 
advice. 
SITE OF CARCINOMA 
In the present study among the total of 25 (100%) subjects, 3(12%) 
had carcinoma in the tongue, 12(48%) had in the buccal mucosa, 5(20%) 
had in the alveolar mucosa, 1(4%) had carcinoma in the floor of the mouth 
and 4(16%) in the palate. Oral cancer was mostly seen in the buccal mucosa, 
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followed by tongue, alveolar mucosa, floor of the mouth and palate. This 
consistent with a study done by Prabhu et al 
49 
found the most common site 
of oral cancer was buccal mucosa followed by tongue and other sites.  
Mehrota et al 
53
 stated that oral cancer was the commonest 
malignancy in Allahabad and buccal mucosa was the most common site of 
oral cancer. 
CORRELATION OF LIPID PROFILE IN THE STUDY GROUPS 
The present study found a mean TC in PMD and OSCC as 159.84 
mg%  and 157.56 mg% respectively .The present study also found a 
significantly reduced TC when both the groups were compared with control 
group with p value < 0.01. This is in accordance with  studies conducted by  
Patel et al 
5  
who conducted   study on 184 head and neck cancer patients, 
153 patients with Oral precancerous conditions and 52 controls and found a 
mean TC  of 167.59 mg/dl level in OSCC group and 168.42mg/dl in OPC 
group with p value  of P=0.008 and P=0.014 respectively.  
            This is also consistent with another study conducted by Lohe et al  
3
 
who conducted  study on 70 Oral cancer patients, 70 patients with Oral 
precancerous conditions and 70  controls and found a mean TC  of 178.73 
mg/dl level in OSCC group and 179.17 mg/dl in OPC group with p value  of 
P<0.001  when compared with controls . It was postulated that low levels of 
cholesterol in the proliferating tissues and in blood compartments could be 
due to the process of carcinogenesis. 
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            The present study found a mean LDL in PMD and OSCC as 92.44 
mg%  and 91.16 mg% respectively .The present study could not find  a 
significant result in LDL when both the groups were compared with control 
group with p value0.07. This is  consistent with study conducted by Lohe et 
al  
3
 who found a mean LDL  of 118.22 mg/dl level in OSCC group and 
117.14 mg/dl in OPC group with p value  of P=0.317  when compared with 
controls. This is also in consistent with study by Chawda et al 
80 
who 
didnot find a significant decrease in  LDL.  
           The present study found a mean HDL  in PMD and OSCC as 40.72 
mg%  and 38.92 mg% respectively .The present study also found a highly 
significantly reduced HDL when OSCC  group was compared with control 
group with p value < 0.001 and significantly reduced HDL when PMD  
group was compared with control group with p value < 0.05. This is in 
accordance with  studies conducted by  Patel et al 
5  
who found a mean TC  
of  28 mg/dl level in OSCC group and 28.6 mg/dl in OPC group with p 
value  of P=0.000 and P=0.000 respectively.  
            This is also consistent with another study conducted by Lohe et al 
3
 
who found a mean TC  of 40.35 mg/dl level in OSCC group and 39.5 mg/dl 
in OPC group with p value  of P<0.001  when compared with controls . It 
was postulated that low HDL is an additional predictor of cancer and it 
might be a consequence of disease that is mediated by utilization of 
cholesterol for membrane biogenesis. 
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            The present study found a mean VLDL in PMD and OSCC as 27.96 
mg%  and 26 mg% respectively .The present study  found  a significant 
reduced  VLDL when OSCC  group was compared with control group with 
p value <0.05. But there was no significant difference in VLDL when PMD 
group was compared with controls. This is  consistent with study conducted 
by Lohe et al  
3
 who found a mean VLDL  of 20.16 mg/dl level in OSCC 
group and 22.41 mg/dl in OPC group with  P=0.002  when OSCC compared 
with controls and P=0.21 when PMD compared with controls. It is believed 
that tobacco carcinogens induce lipid peroxidation in which there is a 
greater utilization of lipids including total cholesterol, lipoproteins and 
triglycerides for new membrane biogenesis. Cells fulfill these requirements 
either from circulation, by synthesis through the metabolism or from 
degradation of major lipoprotein fractions like VLDL. 
            The present study found a mean TGL  in PMD and OSCC as 141.04 
mg% and 131.16 mg% respectively .The present study did not find  a  
significantly reduced TGL with  p =0.22 when both the groups were 
compared with control group. This is not in consistent with study conducted 
by Lohe et al 
3
 who found a significant decrease in TGL when OSCC was 
compared with control. But our study is in consistent with study conducted 
by Alexopoulos et al 
4
  who did not find  a significant decrease in TGL in 
cancer patients. Our study did not find a significant difference due to 
decrease in sample size.  
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CORRELATION OF LIPID PROFILE WITH GENDER 
 
           When a correlation  was done between lipid profile and gender in the 
present study, no significant differences were found. TC was  more in males 
of PMD group when compared to females and lowest in males of OSCC 
group when compared to females. LDL was more in females of OSCC 
group and lowest in females of PMD group. HDL was more in males of 
PMD group when compared to females and almost same in males and 
females of OSCC group. VLDL was more in males of PMD and OSCC 
group when compared to females. TGL was more in males of PMD and 
OSCC group when compared to females .So, in brief men of PMD had 
higher TC,LDL,HDL,VLDL and TGL when compared to females. Men of 
OSCC group had lower TC, LDL and higher VLDL and TGL with HDL 
almost equal in both the gender.  This is in accordance with a study by   
Alexopoulos et al 
4
 who found that cancer men had significantly lower TC 
and LDL but no significant difference in HDL. Though the present study 
had lower TC,LDL levels in cancer men ,there was no significant difference 
between the control. This could be attributed due to the smaller sample size. 
CORRELATION OF DURATION OF HABITS AND LIPID PROFILE 
IN PMD 
              When a  correlation was done between lipid profile and duration of  
habits in PMD group in the present study , no significant differences were 
found. TC, LDL, HDL,VLDL and TGL were more in subjects with  
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increased duration of habits. This could be a primary study where such a 
correlation is assessed.  
CORRELATION OF CLINICAL TYPES OF LEUKOPLAKIA AND 
LIPID PROFILE  
             The present study found an increase in TC, LDL and decrease in 
VLDL and TGL in homogenous type when compared to speckled 
leukoplakia.HDL is found to be significantly reduced in  Speckled 
leukoplakia (p<0.05). Speckled leukoplakia is reported to be asscociated 
with higher malignant transformation in about 20% of cases. Hence reduced 
cholesterol level is seen in Speckled type as the malignancy is likely to 
develop in this type. It could be used as a malignant marker or to assess the 
malignant transformation. 
 CORRELATION OF GRADES OF OSMF AND LIPID PROFILE  
 
The present study found that TC,LDL,HDL,VLDL and TGL was 
highest in grade 4 ,1 followed by grade 3.There were no patients with grade 
2.The present study could be a preliminary study which attempts to correlate 
the grades of OSMF with lipid profile. However we could not find a 
statistically significant difference, as the sample size may be  small. 
CORRELATION OF DURATION OF HABITS AND LIPID PROFILE 
IN OSCC 
The present study found reduced TC, LDL,HDL and increased 
VLDL and TGL in subjects who used tobacco for a long time. Longer the 
duration of tobacco habit, increased chance of getting oral cancer. Hence 
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subjects with longer duration of habit, have reduced TC, HDL levels. 
However we could not find a statistically significant difference. 
CORRELATION OF CLINICAL STAGES OF OSCC AND LIPID 
PROFILE  
 The  present study found reduced TC,LDL, HDL and increased 
VLDL and TGL in subjects with  stage III and stage IV oral cancer .This 
could be a preliminary study wherein such  a correlation is made. 
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The present study titled “Evaluation of serum lipid profile in Patients 
with Oral Potentially Malignant Disorders and Oral Squamous Cell 
Carcinoma” was conducted in the Department of Oral Medicine and 
Radiology, Ragas Dental College, Uthandi, Chennai and Dr. Rai Memorial 
Medical and Cancer Centre, Chennai, to estimate the serum  levels of 
TC,LDL,HDL,VLDL and TGL in patients with Potentially Malignant 
disorders like Leukoplakia and Oral submucous fibrosis, Oral cancer and to 
compare the values with the  control subjects. 
           A total of 75 individuals were selected for the study. Among the 
study subjects 25 patients were suffering from Potentially Malignant 
Disorders, 25 patients were suffering from Oral Cancer, and 25 patients 
were normal controls. Informed consent was taken from all subjects before 
including them in the study.  
The experimental subjects were made to sit comfortably on a Dental 
Chair. Sterile hand gloves were used during examination of the patients.  
Patients were examined under halogen lamp in the dental chair under aseptic 
conditions and relevant demographic data were collected. Clinical diagnosis 
was made and patients who showed characteristic features of Leukoplakia, 
Oral submucous fibrosis and Oral Cancer were prepared for sample 
collection. 5ml of blood from the patient was taken for the evaluation of 
lipid profile. 
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The study documents the following data: 
 Among the 75 subjects 56(74.7%) were males and 19(25.3%) were 
females. The minimum age of the study subjects was 22 years and 
the maximum age was 70 years. 
 Among the 75 subjects 15(20%) had the habit of smoking, 
32(42.7%) had the habit of chewing, 7(9.3%) had the habit of 
chewing and smoking, 3(4%) had the habit of smoking and alcohol 
consumption and 4(5.3%) had all three habits together with a p-value 
of 0.000 which is statistically significant. Thus a positive correlation 
between smoking, chewing, alcohol consumption and development 
of precancer and cancer has been established. 
 The most common sites for leukoplakia were in the retrocommissure 
area with 5 (45.5%) subjects followed by buccal mucosa 5(45.5%) 
and one in  floor of the mouth. 
 The present study showed all cases of OSMF in the buccal mucosa 
6(42.8%) in Grade III and 4 each in Grades I and IV and none in 
Grade II. 
 Among the total of 25 (100%) subjects, 3(12%) had carcinoma in the 
tongue, 12(48%) had in the buccal mucosa, 5(20%) had in the 
alveolar mucosa, 1(4%) had carcinoma in the floor of the mouth and 
4(16%) in the palate. Oral cancer was mostly seen in the buccal 
mucosa, followed by tongue, alveolar mucosa, floor of the mouth 
and palate. 
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 There was a significant decrease in levels of serum TC, HDL which 
were observed in patients with Potentially Malignant Disorders like 
Leukoplakia and Oral submucous fibrosis. The mean TC in patients 
with PMD was 159.84±15.5 mg % ,the mean HDL was 40.72±3.2 
mg % .LDL,VLDL and TGL were also reduced but not significant. 
 There was a significant decrease in the serum TC, HDL, VLDL in 
patients with oral carcinoma. The mean TC in patients with OSCC 
was 157.44±12.3mg %, the mean HDL was 38.92±2.5 mg % , the 
mean VLDL was  26.00±26.9 mg%. LDL and TGL were also 
reduced but not significant. 
 There were no significant relation between lipid profile in relation to 
gender, duration of habits, clinical types of leukoplakia, grades of 
OSMF and stages of OSCC. 
 Reduced lipid level may be attributed to the production of free 
radicals induced by tobacco carcinogens and excessive use of areca nut. It is 
believed that tobacco carcinogens and excessive use of areca nut induce 
generation of free radicals and reactive oxygen species, which are 
responsible for high rate of peroxidation of polyunsaturated fatty acids. 
Because of lipid peroxidation there is greater utilization of lipids including 
total cholesterol, lipoproteins and triglycerides for new membrane 
biogenesis. Cells fulfill these requirements either from circulation, by 
synthesis through metabolism or from degradation of major lipoprotein 
fractions like VLDL, LDL, and HDL. 
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             To conclude an inverse relationship exists between serum lipid 
profile in Oral cancer and Oral Potentially Malignant disorders. The lower 
serum lipid status may be a useful indicator for initial changes occurring in 
neoplastic cells. The present findings are drawn by a smaller sample size but 
the findings strongly warrant an indepth study on a large sample size of oral 
cancer. Further study with larger sample size and additionally a long term 
follow up of PMD subjects with periodic estimation of lipid profile would 
be needed to establish correlation between a transformation from 
precancerous state to malignancy. Thus lipid profile may be used as a 
marker for malignant transformation in PMD and hence early detection of 
malignancy would give way to early treatment thereby increasing the 
survival rate in these  patients. 
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Group I 
S.No Name Age Sex Habits Duration TC LDL HDL VLDL TRI 
1 Mrs.Rajaamma 35 F Nil  176 100 48 28 141 
2 Mrs.Bethana 23 F Nil  149 86 38 25 129 
3 Mr .Selvam 30 M Smoking 5 182 108 41 33 165 
4 Mrs.Thendral 35 F Nil  176 99 49 28 141 
5 Mr.Sundar 52 M Nil  160 87 40 33 165 
6 Mr.Vinod 25 M Chewing 4 170 103 39 28 143 
7 Mr.Gajapathy 27 M Nil  255 180 40 35 179 
8 Mr.Senthil 29 M Smoking 8 176 112 39 25 127 
9 Mr.Mrajinder 63 F Nil  212 133 41 38 194 
10 Mr.Pandiyan 57 M Nil  136 68 39 28 142 
11 Mr.Sambasivam 37 M Chewing 5 167 88 47 32 163 
12 Mrs.Vijaya 63 F Nil  159 79 41 39 197 
13 Mrs.Daisy 58 F Nil 
 
190 116 43 31 159 
14 Mr.Yogesh 42 M Smoking 15 140 67 40 33 165 
15 Mr.Saravanan 33 M Chewing 7 182 108 41 33 165 
16 Mrmani 44 M Smoking 13 149 80 39 30 152 
17 Mr.Naveen 32 M Nil 
 
189 115 46 28 141 
18 Mr.Raja 37 M Nil 
 
139 70 45 24 123 
19 Mrs.Amala 27 F Nil 
 
189 118 40 31 156 
20 Mr .Ranjith 30 M Smoking 11 176 106 42 28 141 
21 Lakshmi 23 F Nil 
 
149 86 38 25 129 
22 Mr .Basha 40 M Chewing 11 182 104 45 33 165 
23 Mr.Gopal 58 M Smoking 20 190 116 43 31 159 
24 Mr.Murugan 52 M Smoking 15 212 133 41 38 194 
25 Mr.Palani 25 M Nil 
 
170 103 39 28 143 
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GROUP II 
Sno Name Age Sex Type Of 
Lesion 
Habit Duration Site OLType OSMF 
Grade 
TC LDL HDL VLDL TRI 
1 Mr .Selvam 47 M OL S&A 20 RetroCommisure Homogenous  167 100 44 22 114 
2 Mr.Vijayakumar 25 M OSMF C 3   1 158 91 41 27 134 
3 Mr .Mohamad 38 M OSMF C 12   4 187 126 41 20 100 
4 Mr.Babu 35 M OL S 18 RetroCommisure Homogenous  153 83 45 24 121 
5 Mrs.Sathyapriya 35 F OSMF C 7   3 146 84 39 23 117 
6 Mr.Faisal 25 M OSMF C 4   1 147 84 39 24 121 
7 Mr.Sheik 27 M OSMF C 10   3 149 87 37 25 125 
8 Mr.Murthy 43 M OL S 25 Buccalmucosa Speckled  153 83 45 24 121 
9 Mr.Hari 35 M OSMF C 13   3 153 90 39 24 124 
10 Mr.Perumal 44 M OL S&A 18 RetroCommisure Homogenous  149 90 37 22 110 
11 Mr.Eshwaran 35 M OSMF C 17   4 176 112 42 21 107 
12 Mr.Vijay 22 M OSMF C 11   1 167 105 38 24 117 
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13 Mrs.Sowmya 37 F OSMF C 14   3 144 78 40 26 131 
14 Mr.Ahmad 33 M OSMF C 10   4 192 87 47 58 291 
15 Mr.Prabhu 42 M OL S 15 Buccalmucosa Homogenous  164 99 43 21 109 
16 Mr.Saravanan 22 M OSMF C 5   1 190 127 39 24 122 
17 Mr.Sekar 42 M OSMF C 16   4 148 83 38 27 137 
18 Mr.Muthu 48 M OL S 23 Floor of Mouth Speckled  142 70 39 33 168 
19 Mr.Vasu 48 M OL S&Al 28 Buccalmucosa Speckled  164 51 49 64 321 
20 Mr .Abdul 31 M OSMF C 7   3 146 81 40 25 127 
21 Mr.Sekar 48 M OL S 22 Buccalmucosa   148 83 38 27 137 
22 Mr .Shankar 39 M OSMF C 12   3 154 84 37 32 163 
23 Mr.Alayappan 38 M OL S 15 Retrocommissure Homogenous  184 110 39 34 172 
24 Mr.Mari 58 M OL S 27 Retrocommissure Homogenous  170 112 42 21 107 
38 Mr.Durai  M OL S 28 BuccalMucosa Speckled  145 79 40 26 130 
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Group III            
SNO Name AGE SEX HABITS DURATION SITE 
CLINICAL 
STAGING TC LDL HDL VLDL TGI 
1 Ranganathan 51 M S&C 20 BM T3NIMX(3) 134 75 40 19 98 
2 Radhakrishna 49 M S&C 27 ALV RIDGE T3N0MX(3) 159 70 34 55 277 
3 Loganathan 58 M C 19 BM T3N1MX(3) 165 89 37 39 195 
4 Ganesh 55 M C 18 PALATE T3N0MX(3) 144 71 41 32 158 
5 Nahoor 62 M S,C&AL 30 ALV RIDGE T2N2MX(4) 142 84 38 19 99 
6 Arulraj 60 M S,C&AL 20 BM T2N2MX(4) 155 88 39 27 138 
7 Annama 70 F C 30 PALATE T3N1MX(3) 141 84 34 23 118 
8 Sampath 63 M C 25 BM T2N1MX(3) 170 111 41 18 94 
9 Dhanalakshmi 67 F C 30 FOM T1N0MX(1) 165 108 39 18 90 
10 Venkatesan 64 M S,C&AL 20 BM T2N0MX(2) 175 112 43 20 99 
11 Paramasivam 58 M S&C 18 PALATE T1NIMX(1) 155 85 38 27 137 
12 Ramadoss 53 M S&C 17 BM T1N0MX(1) 163 102 39 22 110 
13 Kamala 46 F C 25 BM T1N1MX(1) 174 119 40 15 75 
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14 Pushpa 50 F C 15 TONG T1N0MX(1) 171 105 40 15 75 
15 Pushpalatha 63 F C 28 BM T2N2MX(2) 171 109 39 23 115 
16 Sivasubramani 59 M C 20 BM T2N2MX(2) 170 104 40 26 133 
17 Mangavalli 67 F C 30 ALV RIDGE T2N0MX(2) 175 113 41 21 134 
18 Abdulshrif 50 M C 16 BM T4N0MX(4) 145 75 40 30 150 
19 Visalam 66 F C 32 ALV RIDGE T2N2MX(4) 154 87 40 27 138 
20 Bagyam 70 F C 32 TONG T3N1MX(3) 143 78 45 20 100 
21 Muthu 61 M S&C 23 BM T4N0MX(4) 153 83 44 26 130 
22 Naseran 59 F C 22 TONG T2N2MX(4) 162 86 38 36 180 
23 Kannayirum 65 M S,C&AL 32 BM T4N0MX(4) 151 85 42 24 120 
24 Arulnayagam 58 M S&C 17 PALATE T3N0MX(3) 142 83 37 22 110 
25 Mustafa 53 M S&C 19 ALVRIDGE T4N0MX(4) 160 84 36 40 200 
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RAGAS DENTAL COLLEGE & HOSPITAL 
2/102, East Coast Road, Uthandi, Chennai – 600119 
DEPARTMENT OF ORAL MEDICINE & RADIOLOGY 
 
CASE SHEET PROFORMA 
                                                                                                                         
Date: 
S.No     : 
OP.No     : 
Study group    : Group I / Group II / Group III 
Name     :                                                                                            
Age/Sex    : 
Address    : 
Phone number    : 
Occupation    : 
Monthly income   : 
Past medical /surgical/dental /history 
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HABITS 
 
PRESENT 
 
ABSENT 
 
DURATION  
 
Smoking 
     
 
Chewing 
     
 
Alcohol 
     
  : 
Leukoplakia : 
    Site : 
    Size : 
    Type : 
Oral submucous fibrosis : 
    Grade :  
Oral Squamous cell carcinoma 
     Site : 
    Size : 
    Type: 
    Clinical staging: 
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LIPID PROFILE: 
 
PARAMETERS/ 
 
LESION 
TOTAL 
CHOLESTEROL 
(TC) 
 
(mg%/) 
LOWDENSITY 
LIPOPROTEIN 
(LDL) 
(mg%) 
 
 
HIGHDENSITY 
LIPOPROTEIN 
(HDL) 
(mg%) 
 
VERY 
LOWDENSITY 
LIPOPROTEIN 
(HDL) 
(mg%) 
 
TRIGLYCERIDE 
(TGL) 
(mg%) 
 
Potentially 
malignant 
 disorders 
         
Oral Squamous 
Cell Carcinoma 
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WRITTEN CONSENT OF THE PATIENT 
CONSENT LETTER 
 
I          the undersigned hereby give my consent for the 
performance of diagnostic test on myself to "Evaluation of Serum Lipid Profile in 
Patients with Oral Potentially Malignant Disorders and Oral Squamous Cell 
Carcinoma -A Case Control Study " conducted by Dr. S. Srividhya under the able 
guidance of Dr. S. Shanmugam MDS. Professor and HOD Dr. S. Elangovan MDS, 
Professor, Department of oral Medicine and Radiology, Ragas Dental College and 
Hospital, Chcnnai. I have been informed and explained the status of my disorder, 
evaluation procedure risk involved and likelihood of success. I also understand and 
accept this as a part of study protocol thereby voluntarily and unconditionally give 
my consent without any fear or pressure in mentally sound and conscious state to 
participate in the study.  
Witness, Representative      Patient Signature 
(if any)       Date: 
 
 
